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Introduction
1. HISTORY
A. The pre-DBS era
The first operation in the treatment of movement disorders was performed in
1909, by Sir Victor Horsley-''. He performed cortical extirpations to alleviate
athetosis. Since then, many extirpations and transsections in various parts of the
corticospinal tract have been performed to treat hyperkinesias and Parkinson dis-
ease. In 1939, Rüssel Meyers introduced lesioningofthe extrapyramidal system.
In these procedures the head of the nucleus caudatus, parts of the putamen and
globus pallidus, and the ansa lenticularis were successively dissected or
transsected. These operations had a high complication rate, not only because of
causing damage to the targeted structure (and its environment), but also because
of damage to more superficially located parts of the brain that had to be passed to
reach the deep seated structures. For this reason, the first application of a
stereotactic device by Spiegel and Wycis in 1947 was a milestone in the history of
functional neurosurgery: the intended structure, called the target, could be
reached by a small burr hole, thus sparing more superficially located structures.
Initially these so-called "closed" functional operations were mainly performed in
patients with intractable pain. In 1952, Spiegel and Wycis made lesions in the ansa
lenticularis, globus pallidus and dorsomedial nucleus of the thalamus in patients
with hyperkinetic phenomena.
In 1953 Cooper discovered by chance that ligation of the anterior choroidal
artery resulted in an improvement in symptoms in a patient with Parkinson dis-
ease (PD)^'\ The effect was caused by softening of the globus pallidus and its
eßerents. Subsequently pallidal lesions, or "paliidotomies", were performed in
larger series of PI) patients. The changeover from pallidal to thalamic lesions was
initiated by Hassler who not only performed thalamotomies in patients with
tremor, but later also in patients with Tourette syndrome'". In 1969, Spiegel and
Wycis were the first to create lesions in the subthalamus in patients with
They limited their lesions to the fibres located ventral to the subthalamic nucleus,
(STN) thereby avoiding this nucleus itselfbecause of fear of evoking hemiballism.
By 1969 the results of more than 37,000 stereotactic operations had been pub-
lished^''. The vast majority of these had been performed in patients with FD, in an
attempt to alleviate tremor and rigidity. At this time, levodopa became generally
available. This medication seemed to have a spectacular effect on all parkinsonian
symptoms, including akinesia, and consequently the number of stereotactic oper-
ations declined dramatically. However, as a result of the shortcomings of
levodopa therapy in the long-term treatment of FD, the thalamotomy gradually
regained its place, and in 1992, pallidototnies were reintroduced by Laitinen"'
It was in the field of intractable pain that deep brain stimulation (DBS) was used
for the first time. In 1973, a report appeared on chronic thalamic stimulation in
five patients with anaesthesia dolorosa'^.
In 1987, Benabid introduced DBS of the ventral intermediate thalamic nucleus
(VIM) in the treatment of tremor. In patients with bilateral Parkinson tremor, a
VIM tli.il.imotomy was performed contralateral to the more disabled side, and
chronic VIM stimulation on the other side\
B. DBS from 1987 to 2003
Since 1987, unilateral and bilateral thalamic DBS has been performed on a wide
scale in patients with tremor. In 1991 Benabid stated that "this reversibility and
adaptability, allowing control of side effects, make thalamic stimulation prefera-
ble to thalamotomy, especially when treatment of both sides ot the brain is
needed". "• In a huge series of patients with Parkinson disease and essential tremor
with a follow-up of more than 8 years, a 85% reduction in tremor was obtained.^'
A recent double-blind study by Schuunnan et al compared the efficacy and safety
of unilateral and bilateral thalamotomy versus thalamic DBS^. Both procedures
provided a significant improvement in tremor, but adverse effects were much
more common in the thalamotomy-treated group. The study concluded that
thalamic DBS is better tolerated and provides a greater functional improvement
than thalamotomy in FD patients with severe tremor.
Thalamic 1 )BS has an almost exclusively anti-tremor effect with no improvement
in other cardinal features of FD or levodopa-induced dyskinesias.
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In 1992. Siegfried introduced DBS of the ventroposterol.uer.il globus pallidus
intemus (GPi) as a new therapeutic approach for alleviating all parkinsonian
symptoms-*. Although these positive preliminary results had been continued by
others in short-term follow-up studies, large studies with long-term follow-up
review are lacking.
The discovery that primates treated with MPTP (l-methvl-4-phenyl-l. 2, 3,
6-tetrahydropyndme) provided an almost perfect animal model tor uiiopathic
PD, shed new light on the pathophysiology of the disease. An important discov-
ery was that striatal dopamine deficiency led to an electrical hyperactivity of the
STN-.
After promising results of STN DBS in MPTP-treated primates''. Benahid per-
formed the first STN DBS in a PI) patient in 1993*'. Nowadays, the STN is con-
sidered to be the target of choice for patients with advanced PD, with a good
effect on all cardinal motor symptoms.
2. AIM AND OUTLINES OF THIS STUDY
In this study the role of DBS in advanced PD is re-evaluated and new indications
in the field of movement disorders are explored.
The benefit of thalamic stimulation to tremor patients has been broadly estab-
lished since its first application'.3.4.M.II.I.VU.Is.i7.IH.I«J.23.24.ForPD, however, the
situation seems to be different: starting with DBS of the thalamus, surgeons
moved to the GPi aiming to reduce .ill Parkinson symptoms, and eventually
ended up at the STN.
This study commenced in January 1996. Unilateral pallidal stimulation was per-
formed in selected patients with idiopathic PI) with unilateral or asymmetric dis-
tribution of symptoms and, despite optimal pharmacological treatment, severe
response fluctuations and/or dyskinesias. In chapter 1, we analyze the long-term
motor effect of unilateral pallidal stimulation in 26 patients.
Between June 1997 and September 1998, patients were selected for STN DBS if
they had clinical findings consistent with idiopathic PD with bilateral and/or axial
symptoms. Many reports have been published on the long-term benefits of STN
DBS in PD, but all with limited follow-up. Chapter 2 presents the literature on
the long-term effects of bilateral STN DBS in PD and the outcome of our own
series of 32 patients with a follow-up of 4 years. The beneficial as well as the
unwanted effects of bilateral STN stimulation at long tenn are discussed.
In chapter 3, we describe the effects of STN DBS in multiple system atro-
phy-parkinsonism (MSA-P). MSA-P is a highly incapacitating disease with a
short life-expectancy and very few treatment options. Only two patients with
MSA-P who underwent bilateral STN stimulation have been reported in the litera-
ture. Because of short-term unsatisfactory results, the electrodes were removed in
one patient. We present the long-tenn effects of bilateral STN stimulation in four
patients with MSA-P and compare these to the effect of natural disease progression
by evaluating the patients when both stimulators are switched off.
Whereas PD and MSA-P are mainly characterized by hypokinesia, we explored
the possible role of DBS in a hyperkinetic disorder, namely Tourette syndrome
(TS). TS is a chronic neurological disorder with onset in early childhood and
characterized by tics. Tics are sudden, brief, intermittent, involuntary or
seiinvoluntary movements (motor tics) or sounds (phonic or vocal tics). Fre-
quently, TS is found to be a self-limiting disorder as the patient reaches adulthood
whereas in a small proportion of the patients the tics continue into adult life and
require long-term medication. Behavioral therapy has not been proven to be
effective .it long tenn. In chapter 4 we present an extensive review of procedures
that have been performed on lourettepaneiusin ml- {jaM,-aii'LrCruhinH.cnt\üsr<!H
of making lesions in various parts of the brain.
In chapter 5, we introduce DBS as a new therapeutic approach in intractable TS.
We performed the first DBS in a patient with intractable TS-* in 1997. In this last
chapter, we present the long-term outcome of bilateral thalamic stimulation in
three patients with TS.
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CHAPTER 1
Long-term motor effects of unilateral pallidal
stimulation in 26 patients with advanced
Parkinson disease
Veerle Visser-Vandewalle, Chris van der Linden, Yasin Temcl,
Fred Nieman, Halime Celik, F.niilc Uculs.
99. 70/-707. 200.»
Abstract
Ofc/fff. The aim of this study was to evaluate the long-term effects of unilateral
pallidal stimulation on motor function in selected patients with advanced Parkin-
son disease (PD).
jV/ff/ior/j. The authors enrolled 26 patients with idiopathic PD in whom there
was an asymmetric distribution of symptoms and, despite optimal pharmo-
cological treatment, severe response fluctuations and/or dyskinesias. After the pa-
tient had received a local anesthetic agent, a quadnpolar electrode (Medtronic
model 3387) was implanted at the side opposite the side affected or, if both sides
were affected, the side coiural.itcr.il to the more affected side. No serious compli-
cations occurred. After 3 months, the total Unified PD Rating Scale (UPDRS)
_ Pan III score decreased by 50.7% while patients were in the off-medication state
3
M (from 26.5 ± 9.2 to 13.1 ± 6.1) and by 55.4% while they were in the on-medica-
uu'ii s u u ^irViiu i i l . O ' . ^ \ i .O ! < . / - i . ) "'_-'-i.A/4V/O7l<<..«li«K^wi.*}i.» . o n star« U I K rKi
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contralateral effect clearly more pronounced. The UPDRS P.irt IVa score de-
creased by 75% (from 3.7 ± 2.5 to 0.9 ± 1.1). and the UPI )RS Part I Vb score by
54.7% (from 3.3 ± 1.3 to 1.5 ± 1.3).
At long-term follow-up review (32.7 ± 10.7 months), there was an 8.3% in-
crease in the UPDRS Pan III score while patients were in the off state (from 26.5
+ 9.2 to 28.7 + 7.6), and .i 40.2% increase in this score while patients were in the
on state (from lo.d ± 6.3 to 14.9 ± 5.1). The UPDRS Part IVa score decreased
by 28.1% (from 3.7 ± 2.5 to 2.7 ± 2.3), and the UPDRS Part IVb score increased
by 3.5% (from 3.3 ± 1.3 to 3.4 ± 1.6).
Cow/iuJWM. Based on these unsatisfactory results at long-term review, the au-
thors conclude that unilateral pallidal stimulation is not an effective treatment op-
tion tor patients with advanced PD.
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The GPi has been of interest to neurosurgeons in the treatment of PD since the
middle of the 20'*" century-V Initially, the target was located in the anterior and
mediodorsal portion of the nucleus, but these medi.il pallidotomies only had an
effect on rigidity, and not on tremor. In 1956. I eksell moved the target toward
the ventroposterolateral portion of the CIPi. and equal effects on tremor, rigidity
and bradykinesia were reported. In 1992, Laitinen and colleagues'"* published the
results of a large series of ventroposterolateral pallidotomies. which had been
undertaken over an extended period of time. The results showed that this proce-
dure gave long-lasting relief from akinesia and rigidity; other authors have since
confirmed the relevance of the lesion.
After the discovery that high frequency DBS has the same effect on symptoms as
lesions but with fewer complications, the possibility of adjusting the effect over
time and the chance of performing bilateral surgery led Siegfried to become the
first to perform chronic palhdal electrostimulation in 1994'"*.
Several reports have appeared on the effect of palhdal stimulation. As shown in a
recent study-*', it is difficult to interpret the results because of several factors, and
large studies with long-term follow-up review are lacking. In general, the reports
agree that there is a strong postoperative drug dependency, whereas drug-related
side effects, more specifically dyskinesias, arc directly counteracted by the Stimu-
lation.
Injanuary 1996 we embarked on a technique of stereotactic surgery performed in
patients with advanced PD. Because authors of several studies had reported bene-
ficial effects of unilateral pallidotomy on parkinsonian symptoms'- "• 23. ^ and
because DBS had proved to have fewer complications-'*, we decided to start with
unilateral pallidal stimulation in selected patients. In previous studies we reported
on cognitive outcomes'" and changes in the quality of life*' following unilateral
pallidal stimulation in patients with PD.
In this report we prospectively analyse the long-term effects of unilateral pallidal
stimulation on motor function.
CLINICAL MATERIAL AND METHODS
Patient population
Between January 1996 andjune 1997 patients were selected for unilateral pallidal
stimulation if they had clinical findings consistent with idiopathic PD accompa-
nied by asymmetric distribution of symptoms and, despite optimal pharmacolog-
ical treatment, severe response fluctuations and/or dyskinesias. Good initial
response to levodopa was an absolute criterion. The one exception to this was the
inclusion of patients who demonstrated levodopa-resistant rest tremor. Exclusion
criteria included significant atrophy, multiple white matter lesions, or other focal
brain abnormalities on MR images; parkinsonism due to known causative factors,
Hoehn and Yahr stage V at the best moment of the day; a score less than 24 on the
Mini-Mental State Examination; psychosis;and general contraindications for sur-
gery such as severe hypertension or blood coagulation disorders.
Surgery
Stereotactic surgery was performed using local anesthesia and the Leksell G frame
after overnight withdrawal of antiparkinsonian drugs. The target was chosen in
the external segment of the GPi with the following coordinates: 18 to 22 mm lat-
eral to the AC-PC line, 4 mm anterior to the midcommissural point, and 2 mm
inferior to the intercommissural line. In the first 10 patients the target was defined
using both CT scanning and ventriculography. It became clear that target calcula-
tion performed using ventriculography added no extra value to target calculation
— performed using computerized tomography alone, and we therefore decided to
§ omit the ventnculograpliy measurement in the remaining patients.
After tmkinir ;i pnvnrnnal burr hole, a rii*id monopolar test- stimulation elec-
1 ft
trode (diameter 1.8 mm with a 2 mm naked tip, model 3101; Radionics, Ghent,
Belgium) was introduced 6 mm above the presumed target. Stimulation was initi-
ated with a frequency of 100 Hz and a stimulus duration ofO. 1 ins, and it was con-
tinued stepwise every 2 mm, until 4 mm below the target. At each step the stimu-
lus intensity was increased at increments of 0.5 V until the desired response was
achieved or until unwanted side effects occurred. At each point of the test stimu-
lation, the clinical response was evaluated by one neurologist (C.v.d.L.) blinded
to the presence of the stimulation. The following clinical parameters were
assessed using the U1M )RS: tremor (if present) and rigidity in all four extremities;
rapid finger movements; closing and opening of the hands; and dorsiflexion and
plantar flexion of the feet and leg movements. If a clinical response was not pres-
ent .it or several millimeters below the target, the electrode was withdrawn and a
second target through a different trajectory-2 nun anterior, posterior, medial or
lateral to the initial target-was chosen. If necessary, additional adjacent trajectories
were selected. After determination of the optimum stimulation site, the
monopolar electrode was replaced by the final quadripolar electrode (model
3387; Medtronic, Kerkrade, The Netherlands), with the second deepest pole at
the level of the best clinical result. At the level of the burr hole, the electrode was
fixed with methvl metacrvlate and connected to an extension cable, which was
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externalized about 7 cm from the burr hole and connected to an external pulse
generator (model 3625; Medtronic). If I week of evaluation with test stimulation
had shown a clear effect on parkinsonian symptoms, a second operation was per-
formed while the patient was in a state of general anesthesia for the subcutaneous
implantation of the pulse generator (Itrel 2 model 7425 in 13 patients, and Itrel 2
model 7424 in the other 13 [Medtronic]).
Clinical evaluation
Motor performance was evaluated using part III, dyskinesias using part IVa, and
motor fluctuations using part IVb of the UPDRS ' ' . Preopcrativc UIM )RS Part
III assessments were conducted in the best on-medication state (on state) and the
practically defined off-medication state (of! state), as described in the (.'ore Assess-
ment Program for Intracerebral Transplantations in patients with I'D
(CAPIT-PD)-*. Postoperative UPI >RS Part III scores wore evaluated during the
best on and the practically defined off states with the stimulator on. I or motor
subscores the following questions from Part III were used: for rest tremor, Ques-
tion 20 (maximum score 26); for rigidity. Question 22 (maximum score 20); for
bradykinesia. Question 31 (maximum score 4); for .ikmcsi.i, Questions 23
through 26 (maximum score 32); for gait. Question 2'J (maximum score 4): and
for freezing. Question 14 of Part II (maximum score 4). Dyskinesias and daily
appearance and predictability of offpenods were evaluated using UPI )RS Part I V.i
(dyskinesias; maximum score 13) and Part IVb (motor fluctuations; maximum
score 7) scores both preoperatively and postoperatively witti the stimulator on.
Medication use
Medication intake was defined by the levodopa equivalent dose (LED), which
equals 100 ing levodopa or 133 mg of levodopa modified-release preparations, or
1 mgpergolide. lOmgbromocryptine, 1 mg cabergoline, 6 mgropinirole, 1 mg
lisuride, or 20 mg apomorphine.
Statistical analysis
Data are presented as mean values ± SDs. Changes between preoperative base-
line, 3-month follow-up, and long-term follow-up were analysed using the
paired Student t-test and the Wilcoxon signed-rank test.
This was repeated for both off and on states and for both sides (contralateral and
ipsilateral) in each clinical parameter. Differences in follow-up values, compared
with baseline values in the off state were compared with the same differences in
the on state by applying repeated- measures analysis of variance, in which double
paired t-tests are performed. Triple paired t-tests are also performed in this way,
when the difference between contralateral and ipsilateral sides were compared
over time in both the offand on state. Along with all these paired t-tests a more
comprehensive analysis was performed in which the patient's linear changes over
time were expressed as one overall parameter. The calculation of the ordinary lin-
ear slope over time was complicated by the variable moment at which long-term
follow-up results were measured: this could vary between 6 and 49 months after
the operation. Weights found in unequal-distances first-order orthogonal poly-
nomials were used to calculate individual linear slopes over time. Next, mean lin-
ear slopes in contralateral measurements, averaged for both the offand on states of
the patients, were compared with those in ipsilateral measurements by means of
the paired Student t-test and also by the Wilcoxon signed-rank test. To assess the
relationship between preoperative differences in contralateral and ipsilateral
scores and linear- slope differences between the same scores the Pearson correla-
tion coefficient was used. To control for both age and sex, a regression analysis
was performed to test the statistical significance of this relationship by means of its
partial standardized regression or ß coefficient. A probability value less than 0.05
is considered to be statistically significant. All data were analyzed using a commer-
cially available statistical software program(SPSS-pc, version 11.0.1; SPSS Inc.,
Chicago, IL).
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Twenty-six patients (20 men and six women) were included in this study. The
mean age of these patients at the time of diagnosis was 43.1 ± 10.5 years and the
mean age at the time of surgery was 56.2 + 8.6 years. Patient profiles are listed in
Table 1. The side chosen for stimulation was either contralateral to the side
affected or, if both sides were affected, contralateral to the more affected side.
The mean number of trajectories necessary to find an optimal clinical result dur-
ing test stimulation was 2.44 (range 1-9 trajectories). No incidence of bleeding or
serious side effects was encountered. Four patients displayed confusion for a max-
imum of 3 days after the electrode implantation. One patient suffered pain due to
traction on the extension cable after implantation of the pulse generator; the pain
disappeared after an Itrel augmentation procedure.
Results are presented 3 months after surgery and at long-term follow-up review,
which occurred at a mean of 32.7 months (range 6-49 months).
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Table 1 Chanctensoo of 2b paaencs receiving unilateral GPi «tunulaoon
ChanetenttK Value
Sex (no. of paoenB)
male
female
Age (yn) al disease omet
mean ± SD
Apr (yn) at turgery
mean ± SD
range
Disease duration (yn)
mean + SI)
range
No. of patient* with tremor
No. of patient» with dyüuneuas
Mo« affected tide (no. of patients)
left
right
Follow-up (mot)
mean ± SI)
range
No. of patients with follow-up > 24 mot
2«l
6
4.V1 ± 10.5
20-60
56 2 ± 8.6
38-67
13.1 ± 5 0
5-21
IH
21
11
IS
32.7 ± 10.7
6-49
Overall effect on motor function
At 3 months postoperatively, significant improvements were found in global lat-
eral motor symptoms, as well as in bodv bradykinesia and gait, during off and on
states. Freezing did not improve significantly. For all these symptoms, with the
exception of akinesia, the improvement was significantly more pronounced
while the patient was in the on state than in the off state (0.001 <p<0.014). The
total UPDRS Fart III score did decrease by 50.7% (from 26.5 ± 9.2 to 13.1 ± 6.1)
in the off state, and by 55.4% (from 10.6 ± 6.3 to 4.7 ± 4.4) in the on state (p
<0.0() 1). These differences in effect between the off and on states were most pro-
nounced for body bradykinesia (p<0.001; difference was 65.2% [from 2.7 ± 0.8
to 0.9 ± 0.7] in the off state and -81% (from 0.6 ± 0.7 to 0.1 ± 0.3 J in the on state),
and for gait (p=().OO5; difference was -49.3% [from 2.6 ± 1.1 to 1.3 ± 0.6] in the
off state and -57.2% [from 1.1 ± 0.8 to 0.5 ± 0.6] in the on state).
There was a pronounced improvement in dyskinesias, with a decrease of 75%
(from 3.7 ± 2.5 to 0.9 ± 1.1) in the UPDRS Part I Va score and a clear reduction in
Table 2 Companion of motor scorn and medication use in 26 patients who received unilatenl stimulation of the GPi*.
Scoring Factor
OFF STATE
UPDRS Part III total »core
tremor
ngidity
akinesia
bradykinesia
freezing
gait
ON STATE
UPDRS Part III total icore
tremor
rigid] ry
akinesia
bradykinesia
freezing
gait
UPDRS Part IVa score
UPDRS Part IVb score
MEDICATION
LED (ing)
Baseline score
26.5 ± 9.2
3.5 ± 3.6
5.5 ± 3.0
12.3 ± 7.2
2.7 ± 0.8
2.0 ± 1.1
2.6 ± 1.1
10.6 + 6.3
1.2 ± 2.3
2.3 ± 2.0
5.4 ± 4.3
0.6 ± 0.7
0.4 ± 0.8
1.1 ± 0 8
3.7 ± 2.5
3.3 ± 1.3
788 ± 262
3-mo FoDow-up
Score
13.1 ±6.1
1.4 + 2.2
3.0 ± 2.0
6.5 ± 4.3
0.9 ± 0.7
1.4 ±0.7
1.3 ±0.6
4.7 ± 4.4
0.3 ± 0.8
0.9 + 1.4
3.0 ± 3.1
0.1 ±0.3
0.2 ± 0.4
0.5 ± 0.6
0.9 ± 11
1.5 ± 13
821 ± 408
%Change*
-50.7
-62.0
-45.5
-47.2
-65.2
-32.7
-49.3
-55.4
-75.6
-65.2
-44.7
-81.2
-45.5
-57.2
-75.0
-54.7
+4.2
p Value
<0.001
<0.001
<0.001
<0.001
<0.001
0.007
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.170
<0.001
<0.001
<0.001
0.223
Long-Term
Score
28.7 ± 7.6
3.1 ±3.1
6.0 ± 2.7
14.5 ± 4.5
2.3 ± 0.8
2.9 ± 1.1
2.8 ± 0.6
14.9 + 5.1
0.6 ± 1.0
2.0+ 1.8
10.3 ± 3.4
0.4 ± 0.7
1.2 + 0.9
1.5 ±0.6
2.7 ± 2.3
3.4 ± 1.6
1212 + 409
FoUow-up
% Change*
+8.3
-12.0
+9.1
+ 17.8
-14.5
+46.2
+9.0
+40.2
-50.0
-13.0
+90.8
-31.3
+ 172.7
+39.3
-28.1
+3.5
+53.8
p Value
0.244
0.453
0.416
0.099
0.096
0.001
0.207
<0.00l
0.088
0.381
<0.001
0.232
0.001
0.005
0.036
0.713
0.001
3-Mo/LTp Value
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.043
<0.001
<0.001
0.029
<0.00l
<0.001
<0.001
<0.00l
<0.00l
*Valucs are expressed as means ± SD; Percentages of change with respect to baseline value (+= increase, —= decrease)
Abbreviation: 3-mo/LT = results at long-term follow-up compared with results at 3-month foUow-up
Tabl« 3 Outcome Kores of lateral motor symptoms in 26 patients who received unilateral GPi somulabon: comparison of effect» contn- and ipnlatcral to the tide of nrmilation.
3-Mo FoUow-Up (contralat/ipsilat) Long-Term FoUow-up (contralat/ipnlat)
3-mo/LT
Scoring Factor
Baseline Score
(contralat/ipsilat) Score % Change p Value Score % Change p Value p Value
OFF STATE
Ul ' l ) R S Part III total
tremor
nguiitv
ukincsu
ON STATE
Ul'l )RS Part III total
tremor
rigidity
1H5+4.9/13.0+5.7
2.5+2.3/0.7+1.4
3.211.7/2.4+1.6
7.613.7/4.7+3.8
7.813.8/4.6+3.4
1.0+1.6/0.2+0.7
1.7+1.2/0.7+1.1
3.5+2.4/2.0+2.2
9.5+3.8/5.8+3.4
1.111.7/0.210.7
2.0+1.2/1.0+1.0
4.212.5/2.4+2.2
2.0+2.1/3.313.0
0.110.4/0.2+0.6
O.I 10.4/0.711.0
1.2+1.6/1.8+1.9
-4S.6/-55.8 <0 001/<0.00l
-56.1/-68.4 <0.001/<0.030
-36.1/-68.4 <0 001/<0.001
-45.2/-50.4 <0.001/<0.001
-74.4/-27.7 <0.()0l/<0.00l
-88.0/-16.7 ().a)7/0.327
-93.2/+5.6 <0.00l/0.574
-65.5/-7S <0.001/0.46l
1» 914.6/14.7+4.1
2 4+2.2/0.7+1.)
3 4+1 4/2.6+1.6
8.2+2.7/6.4+4.1
+2 I/+12.7
-76/-5.3
+4.8/+9.8
+76/+34.2
0.718/0 IVI
0.593/0.857
0.703/0 513
0.427/0.022
0.469/<0.001
0.015/0.212
7.4+2.7/9.4+3.3 -4 9/+104.2
0.2+0.5/0.4+0 7 -8O.0/+66.7
02+05/18+14 -864/+I55.6
5 1+2.0/5.3+2.0 +467/+I68.6 <0.00l/<0.001
<01)01/<0 (XII
0.01)1/<0.(XII
<0.001/<0.00l
<0.00l/<0.(»0l
<0.001/<0.00l
0161/0.134
0 I85/<O.OOI
<0 001/<0.001
I
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motor fluctuations, with a decrease of 54.7% (from 3.3 ± 1.3 to 1.5 ± 1.3) in the
UPDRS Part IVb score.
At long-term follow-up review, there was a significant worsening oflateral symp-
toms, body bradykinesia, freezing, and gait when scores were compared with
3-month follow-up scores. Compared with baseline, the only significant change
in the ofFstate was a worsening of the score for freezing: 46.2% (from 2 ± 1.1 to
2.9 ± 1.1). Also in the on state there was no significant improvement in any item
compared with baseline scores. On the contrary, there was a significant worsen-
ing of the UPDRS Part III total score (40.2% [from 10.6 ± 6.3 to 14.9 ±5.1]) and,
specifically, in akinesia (9().H% from [5.4 ± 4.3 to 10.3 ± 3.4)) and freezing
(172.7% [from 0.4 ± 0.8 to 1.2 ± 0.9)). The improvement in dyskinesias
(UPDRS Part IV a) was significantly less pronounced (p<0.001) than the
improvement at 3 months (-28.1%[ from 3.7 ± 2.5 to 2.7 ± 2.3]). Motor fluctua-
tions (UPDRS Part IVb) did not show any change compared with baseline.
Comparison of contralateral and ipsilateral effects
of stimulation
— At 3 months postoperatively, there was a statistically significant change between} contralateral and ipsilateral improvements in motor function in the ofl" state
(Table 3). 1 hiring the offstate the change in the UPI )RS Part 111 score was -48.6%
(from 18.5 ± 4.9 to 9.5 ± 3.8) on the contralateral side and -55.8% (from 13 ± 5.7
to 5.8 + 3.4) on the ipsilateral side (p=0.009). During the on state, the improve-
ments were clearly more pronounced on the side contralateral to the stimulation,
with a decrease of 74.4% (from 7.8 ± 3.8 to 2.0 ± 2.1) in the contralateral UPDRS
Part III score, and 27.7% (from 4.6 ± 3.4 to 3.3 ± 3.0) in the ipsilateral score
(p—0.001 for the difference between on and oft states).
At long-term follow-up review, this difference in sides in the on state was even
more pronounced, with a decrease in the contralateral UPDRS Part III score of
4.9% (from 7.8 ± 3.8 to 7.4 ± 2.7), and an increase in the ipsilateral UPDRS Part
III score of 104.2% (from 4.6 ± 3.4 to 9.4 ± 3.3). The poor effect in the
contralateral UPDRS Part III score in the on state was mainly due to a worsening
of contralateral akinesia (46.7% [from 3.5 ± 2.4 to 5.1 ± 2]). At long-term fol-
low-up review there was no significant improvement in any lateral motor symp-
tom, either ipsilaterally or contralaterally.
Table 4 shows the means, SDs, and score ranges for the linear slopes in the
UPDRS Part III for both contralateral and ipsilateral sides for both off and on
states in the 26 patients. Using the paired t-test in both the offand on state, patients
scored preoperatively higher on the contralateral side than on the ipsilateral one
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Table 4 Mean*. SIX and wore rang» lor UPORS III preoperatise worm and linear slope scorn m 2b
panenc who received unilaieral paludal stimulation oi the CIpi*
Pres>p Scores Linear Slope Score»
Side & Clinical Condition
Contralateral off «ate
on Mate
Ipulateral otf «ate
on «ate
Mean ± SO
18S4±4 86
7.81 ± .V77
13.04 ± 5.73
4.5« ± 3.43
Range
8 to 27
1 to 17
2 to 24
Uto 12
Mean ± SO
3 23 ±3.81
1 66 ± 1 K2
3 75 ± 3 76
M l t J (H
Range
-4.17 to +13.43
-l.5f.to + 4»K>
-2 7Sto +13 18
H ( l ' ) M 1 S 1 1
•The dopes are calculated through three measurement in tiinr ipreoperativelv. JI I inoiiihv postoperativelv
and it lon|(-lerm follow-up review) A lower dope store stands lor J relative iinproxrinem in ihr >lmual
condition, a zero slope stands tor "no change." and J higher slope lor a »lmu.il ilclcnorjlion
(p<O.(X)l). Averaging over both states there was still a statistically significant dif-
ference in the contralaterj] side, compared to the ipsil.iter.il side, in baseline
UPDRS Part III scores (p«).<M)l). The mean difference between sides for all
patients was 4.37 ± 2.95 (range -0.50 - 11.5).
Using the paired t-test there was no significant difference between the slopes of
the contralateral and ipsilateral sides in the off state (p = 0J21), but there was a dif-
ference in the on state (p<().( X) 1). Averaging over both states there was still a statis-
tically significant difference between the contralateral and ipsilateral sides in
UPDRS Part III progression in time (p«>.<H)|): on the contral.iter.il side the
patient fared better over time due to stimulation.
Regression analysis can be used to investigate the possible predictive power of the
preoperative UPDRS Part III scores for the individual linear slope progression in
these scores.
Calculating the Pearson correlation coefficient between slope progression and
the preoperative difference between contralateral and ipsilateral scores gave a sta-
tistically significant negative correlation coefficient of-0.421 (p=0.016).
Standardiszing for age and sex the ß coefficient of preoperative scores and slope
progression scores remained statistically significant (ß = -0..WJ, p=O.O49). Thus
the larger the preoperative difference between scores on the contralateral and
ipsilateral sides, the higher the linear progression difference between these sides
will be.
Medication use
It was not ou r aim to keep the medication regimen unchanged postoperati vely, as
described by the CAPIT-PD. In accordance with the patients' clinical condition,
we first optimized the stimulation parameters and then adjusted medication use.
The mean LED did not change significantly after 3 months. It increased signifi-
cantly by 53% (from 788 to 1212 mg) at long-term follow-up review.
Stimulation settings
At 3 months, 14 patients received stimulation delivered in a monopolar manner,
compared with 15 patients at long-term follow-up review. At 3 months, the
mean voltage was 2.6 V (range 1-4 V), the mean frequency was 141 Hz (range
130-185 Hz), and the mean pulse width 213 usec (range 120-300 usec). At
long-term follow-up review, the mean voltage was 3.3 V (range 2-6 V), with a
mean frequency of 135 Hz (range 130-185 Hz), and a mean pulse width of 234
UJSCC (range 120-450 usec).
DISCUSSION
The results of this study show that there was a clear effect of unilateral pallidal
stimulation on contra- and ipsilateral motor function, body bradykinesia, and gait
in the off ami on states, as well as on dyskinesias and motor fluctuations, at
short-term (3 months) tollow-up review in selected patients. At long-term fol-
low-up, the only improvement worth mentioning was seen in contralateral
tremor and rigidity during the on phase.
Our short-term motor results (except for freezing in the off state) are better than
those reported in a recently published study in which a 1-year follow-up review
of unilateral pallidal stimulation is described-''. This might be explained by patient
selection. The mean preoperative total UFDRS Fart III score under off-medica-
tion conditions in our study was 26.5 ± 9.2 compared with 57.2 ± 13.7 in the
other study, and the mean preoperative UPDRS Fart III score under on-medica-
tion conditions was 10.6 ± 6.3 compared with 29.1 ± 6.5. Moreover, our patients
were selected on the basis of an asymmetric distribution of symptoms, which is
illustrated by the mean difference between sides, which is 4.37 ± 2.95. The higher
this score is, the higher the preoperative differences in sides. The statistically sig-
nificant negative Pearson correlation coefficient of-0.421 (p=0.016), calculated
between slope progression and preoperative UFDRS Fart III scores, means that
the higher the difference between contralateral and ipsilateral UPDRS Part III
scores, the larger the difference between the contralateral and ipsilateral effect of
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stimulation will be. In other words, the less the lpsilateral side is affected preopera-
tively. the more the patient will benefit from the stimulation lpsilaterally.
Our long-tenn results are worse for any motor item compared with the results of
the aforementioned study-'". The change in the total U1M )RS Part 1II off-medica-
tion score at long-tenn review was 8.3% in our study, compared with -38.3% in
the other study, and the respective changes in UPHRS Part III on scores were
40.2% compared with -28.(>%. The most pronounced difference is seen on the
freezing score ontained in the on state: 172.7% compared with -16.5%.
These huge differences at long-tenn review may be explained by the difference in
follow-up periods: 21 patients in our study were followed for longer than 24
months (maximum 49 months), compared with 12 months m the other study.
These results suggest that the short-ten» positive motor effect of unilateral pallidal
stimulation declines progressively over time. This might be explained as follows.
First of all, at short term, there might be a micropallidotomy effect. It seems to us
unlikely, however, that this is still the case at 3 months, because in many patients
we saw a worsening of symptoms when the stimulator was switched off after 3
months. Furthennore. disease progression might lead to a worsening of symp-
toms that cannot be counteracted by stimulation. At long-term review, there was
a significant increase in the mean stimulation voltage of 23.3% (2.0 compared
with 3.3 V) in our study, with an insignificant increase in pulse width. The
increase in medication was S3.8% (LEI) 821 mg compared with 1212 mg) This
means that the effect of the stimulation was limited, and that an important increase
in medication was necessary.
The results of this study confirm that stimulation of the GPi is a safe procedure. In
a previous study we reported on cognitive outcome after unil.itcr.il pallidal stimu-
lation"". No significant deterioration in cognitive status was seen. In the 1-year
follow-up study mentioned previously, no changes in cognitive function were
reported after 12 months.
In our study no stimulation-dependent behavioral changes were noted. This is in
contrast to our experience with bilateral STN stimulation. In a significant num-
ber of patients who underwent bilateral STN stimulation for advanced I'l) in our
hospital, voltage-dependent behavioral disinhibition was noticed and was some-
times accompanied by hypersexuality and aggression (report in progress). CCom-
parable behavioral changes have been reported by other groups''- "• " . This may
lead to the question of whether pallidal stimulation might be preferable in some
patients who are prone to behavioral changes, despite the superior effect of STN
stimulation on motor symptoms''"'- '*'• 21. 3o. 31. 3V
Particularly for patients who have undergone a pallidotomy and in whom motor
symptoms on the side ipsilateral to the lesion or axial problems like gait freezing
develop, the question could arise: would the patient be better off with
contralateral unilateral pallidal stimulation or with bilateral STN stimulation? A
bilateral pallidotomy bears too many risks, of which speech and psychiatric distur-
bances are the most frequent *• *• '2. 17, 28 ^ unilateral STN stimulation after
pallidotomy is not an option because of conflicting postoperative medication
requirements: in general STN stimulation demands a postoperative reduction of
medication to avoid dyskinesias^, whereas for the side contralateral to the
pallidotomy the patient generally remains strongly medication dependent on
medication^. Moreover, problems with gait freezing and falling have been
reported after unilateral STN stimulation in patients with a unilateral
pallidotomy*''. If one has to consider the risks of bleeding, which theoretically
increase when more electrodes are implanted, a unilateral pallidal stimulation
would be the better option. When the risks of behavioral changes are taken into
account, one would again choose unilateral pallidal stimulation. Our results dem-
onstrate that, despite its safety, unilateral pallidal stimulation is not a good treat-
ment option for patients with advanced PL) because ot the unsatisfactory motor
effects at long-term review, even on the side contralateral to the side of
— stimulation.
t^ It is interesting to note that we found similarities between the long-term effects of
unilateral pallidal stimulation and unilateral pallidotomy. Hariz and
Bergenheim'* reviewed a 10-year follow-up of patients who underwent the
Leksell posterovental pallidotomy for PI). The only symptoms on which the
effect was lasting were tremor and dyskinesias. Most patients exhibited a gradual
recurrence of axial and akinetic symptoms. Similarly Baron, et al', Pal, et aP^ and
Gregory'^ demonstrated that initial improvements in contralateral dyskinesia and
tremor were preserved after unilateral pallidotomy, whereas the improvements in
most other deficits disappeared during follow-up periods lasting 3, 2, and 4 years,
respectively.
Valldeoriola and colleagues™ and Fine, et al.,'* found that significant early
improvements in off-period contralateral signs of parkinsonism were sustained
for 4 and 5.5 yean, respectively, whereas early benefits observed in axial symp-
toms and motor fluctuations waned with time.
The underlying mechanism of the effects of pallidal surgery is not clearly under-
stood*. Moreover, the effects of stimulation both on parkinsonism and
dyskinesias has been shown to vary with the site of stimulation within the pallidal
complex: more ventral stimulation has a better effect on dyskinesias at the cost of
the effect on akinesia, whereas more dorsal stimulation has a better effect on
akmesia at the cost of dyskinesias--". It seems as if a compromise has to be found
concerning which symptoms will be ameliorated and which will not.
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In the case of posteroventral pallidal stimulation, which we performed in this
study, this compromise led to favorable results for some time, as long as the
akinetic symptoms could be ameliorated by increasing the medication. Icvodopa
can be increased to higher levels after pallidal surgery because medica-
tion-induced dyskmesias are counteracted by the surgery. This rise in medica-
tion, however, has its limits, whereas akinetic symptoms progressively decline
due to the natural course of the disease.
We consider it unlikely that patient selection led to poor results in our study. A
preoperative LED of less than I(KH) mg and a good response to levodopa have
been shown to be predictive factors for good clinical outcome in pallidotomy.*'"'
In addition, although this has not been explicitly confirmed in p.illui.tl stimulation
studies, we believe that our patients were excellent candidates for good outcome,
on the basis of strict selection criteria.
CONCLUSIONS
Unilateral pallidal stimulation is a safe procedure that conveys a beneficial effect,
in the short term, on motor symptoms that arc contralateral as well as ipsilatcral to
the side of the stimulation. Long-term results, however, arc unsatisfactory, meaning
that this procedure is not a valid treatment option for patients with .idv.tiu cd IM).
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CHAPTER 2
Long-term effects of bilateral subthalamic
nucleus stimulation in advanced Parkinson
disease
A four year follow-up study
Veerle Visser-Vandewalle, Chns van der l.iiuicn. Yasm Temel,
Halmic Cclik, Linda Ackemuns, Ci. Spinccmaillc, J. Caeinaort
Abstract
iVf. In this study we aimed to investigate the effects of bilateral high-fre-
quency stimulation (HFS) of the subthalamic nucleus (STN) in patients with ad-
vanced Parkinson disease (PI)) at long-term follow-up, with a minimum
follow-up of 4 years.
A/rr/ioi/i. Patients with idiopathic PI) and, despite optimal pharmacological
treatment, severe response fluctuations and/or dyskincsias were selected. Surgery
was performed under local anesthesia. The target was defined on CT-images. N o
depth-recordings were performed. UPDRS II(AI)L), lll(motor performance),
IVa (dyslcinesias), IVb (motor fluctuations), and Schwab and England scores were
evaluated preoperatively during the best on-medication state (on state) and the
practically defined ofi-mcdication state (off state) at 3 months with the stimulators
on, and at 4 years with the stimulators on and off. Twenty patients (15 men, 5
women) were included in this study with a mean age of 60.9 ± 8.1 years. At 3
months follow-up, significant improvements were found in the total UPDRS III
score, m the of) state (from 42.3 ± 4.3 to 19.5 ± 6.4), as well as in the on state
/ii*il?_\»*/\ I/.'. i_+..5.y>. AH.wvotor.iubscorcs.icuproved .yraiificautlv in
the off state. The UPDRS IVa and IVb scores decreased significantly. At
long-term follow-up, there were still significant improvements in the total
UPDRS III motor score (from 42.3 ± 9.3 to 24.2 ± 13.2), as well as in all motor
subscores, in the oh* state, during stimulation. In the on state, the only significant
improvement was scon in rigidity and akmcsia. At 3 months and at long term,
there was .1 significant decrease in the UPDRS II score in the off state as well as in
the on state. The Schwab and England scores increased significantly at 3 months
and .it long-term follow-up.The LED (levodopa equivalent dose) decreased sig-
nificantly with 47.2''" at the long-term follow-up. Complications included
hypomania to mania in four patients. In one, this became apparent only one year
after surgery.
f '('»(/lO'ii'ii. Our results indicate that HFS STN results in long-lasting improve-
ment of the motor symptoms, ADL activities and functional performance in pa-
tients suffering from advanced I'D. The stimulation induced behavioral changes
need special consideration.
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Since the beginning of the 19th century, surgery is performed on patients suffer-
ing from PD. Lesions of the thalamus had a good effect on contralateral tremor,
lesions of the pallidum or Forel's field, had a good effect on contralateral tremor
and rigidity. In 1967 oral levodopatherapy was introduced and. in contrast to the
results of surgery at that time, seemed to have a good effect not onlv on tremor and
rigidity, but also on akinesia. This led to a drastic reduction of the amount ot oper-
ations performed on PD patients. After a few years however, complications of
chronic levodopa-intake became apparent, mainly dyskinesias and on-off fluctu-
ations.This led to a renewed interest in the surgical treatment. In 1985 the atten-
tion was focussed on the globus pallidus. Pallidotomies seemed to have a good
effect on contralateral tremor, rigidity, and, dyskinesias. High frequency stimula-
tion became a safer alternative for performing lesions, which led to a reduction of
the complication rate. The unsatisfying effects olp.illul.il stimulations on akinesia
however, even when performed bilaterally, motivated researchers and clinicians
to search for a better target. The discovery that monkeys treated with MPTP
formed an almost perfect animal model for PD. shed new light on the
pathophysiology ot the disease. An important discovers' was that striatal dopa-
mine deficiency led to an overactivity of the STN. In 1991 Aziz' reported on the
beneficial effects oflesions of the STN in 2 MPTP-monkeys: there was not only a
good effect on tremor and rigidity, but also on posture and spontaneous move-
ments. Both monkeys however developed hemibalhsm. In I9«M Hcnazzouz^
successfully performed high frequency stimulation (HFS) of the STN in 2
MPTP-monkeys, without the development of hemiballism. In 1993 Menabid-'
successfully performed the first STN HFS in a patient with advanced PI) Since
then many other centers followed, and nowadays the STN is generally considered
to be the best target when surgery for patients with advanced PD is considered,
improving all cardinal PD symptoms. More and more reports appear on the
effects at long term, most of them with a follow-up of I to 2 years. In this study we
prospectively analyzed the effects of bilateral STN HFS in 20 patients, with a
minimum follow-up of 4 years.
CLINICAL MATERIAL AND METHODS
Patient population
Between June 1997 and September 1998 patients were selected for STN HFS if
they had clinical findings consistent with idiopathic PD and, despite optimal
pharmacological treatment, severe response fluctuations and/or dyskinesias.
Good initial levodopa response was an absolute criterion. The one exception to
this was the inclusion of patients who demonstrated levodopa-resistant rest
tremor. Exclusion criteria consisted of significant atrophy, multiple white matter
lesions or other focal brain abnormalities on MR-images, parkinsonism due to
known causative factors, Hoehn and Yahr stage 5 at the best moment of the day, a
score <24 on the Mini-Mental State Examination, psychosis, and general contra-
indications for surgery such as severe hypertension or blood coagulation disor-
ders.
Surgery
Stereotactic surgery using the Leksell G frame was performed using local anesthe-
sia, after overnight withdrawal of antiparkinsonian drugs. The target was defined
on CT-images with the following coordinates: 11-12 mm lateral to the AC-PC
line, at the mid-commissural point, and 4 mm inferior to the inter-commissural
line.
After making a precoronal burr hole, a rigid monopolar test stimulation electrode
was introduced with a diameter of 1.8 mm and a naked tip of 2 mm ( model
3101-2; Radionics, Client, Belgium) 6 mm above the presumed target. Stimula-
,^ tion was initiated with a frequency of 100 Hz and a stimulus duration of 1 ms and
C continued stepwise every 2 mm, until 4 mm below the target. At each step the
jJ stimulus intensity was increased at increments of 0.5 V until the desired response
w.is achieved or until unwanted side effects occurred. At each point of the test
3* stimulation the clinical response was evaluated by one neurologist (CvdL)
blinded to the presence of stimulation. The following clinical parameters using
the UPDRS'' were scored: tremor (if present) and rigidity in all 4 extremities,
rapid finger movements, closing and opening of the hands, dorsi- and plantar
tlexion ot the teet and leg movements. If a clinical response was not present at or
several millimeters below the target, the electrode was withdrawn and a second
target through a different trajectory, 2 mm anterior, posterior, medial or lateral to
the initial target, was chosen. As much as possible, we led ourselves lead by the
clinical result: it an adverse motor effect was found at a low voltage (< 3V), sug-
gestive for stimulation of the internal capsule, the second trajectory was made
more medially, it sensory symptoms occured, we went more anterior. After
determination of the optimum stimulation site the monopolar electrode was
replaced by the final quadripolar electrode (model 3389; Medtronic, Kerkrade,
The Netherlands), with the second deepest pole at the level of the best clinical
result. At the level of the burr hole the electrode was fixed with methyl
inctacrylatc and connected to an extension cable, which was externalized about 7
cm from the burrhole and connected to an external pulse generator (model 3625;
Medtronic ). When I week of evaluation with test stimulation showed a clear
effect on parkinsonian symptoms, a second operation was performed under gen-
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end anesthesia, for the subcutaneous implantation of the pulse generator (ltrel 3
model 7425; Medtronic ).
Clinical evaluation
Activities of daily living (ADL) were evaluated using p.irt II. motor performance
was evaluated using part III. dyskinesias using part IV.». and motor fluctuations
using part IVb ot the UPDRS. Lower scores reflect better performances. Func-
tional performance was evaluated through the Schwab and England score (higher
scores correspond with better Performances). Preoperative UPDRS II and III
assessments and Schwab and England scores were conducted m the best on-medi-
cation state (on state) and practically defined off-medication state (otl state) as
described in the CAPIT-PD'\ 4 to 6 weeks before surgery. Postoperative
UPDRS III scores were evaluated in the on and off states with the stimulators on
at 3 months, and with the stimulators on, and 12 hrs otl, at long-term follow-up.
For motor subscores the following questions from part III were used: tor rest
tremor. Question 20 (maximum score 26); for rigidity. Question 22 (maximum
score 20); for bradykinesia. Question 31 (maximum score 4); for akinesia.
Questions 23 through 26 (maximum score 32); for gait. Question 2'' (maximum
score 4); for freezing. Question 14 of part II (maximum score 4). Dyskinesias, and
daily appearance and predictability of oifstates were evaluated with UIM )RS part
lVa (dyskinesias) and IVb (motor fluctuations) with a maximum of 13 .mil 7,
respectively, preoperatively and postoperatively with the stimulators on.
Since all patients kept their stimulators on continuously, postoperative data on
ADL (UPDRS II) and functional performance (Schwab and England) were only
collected in the stiinulation-on condition, in the on and otl state.
All postoperative data were collected in the same sequence, and the patient as well
as the investigator were aware of the medical and stimulator's status.
Medication
Medication intake was defined by the LED (levodopa equivalent dose), which
equals 1 (M) mg levodopa or 133 mg oflevodopa modified release preparations or 1
mg of pergolide. 10 mg of bromocryptine. 1 mg of cabergoline, 6 mg of
ropinirole, 1 mg of lisunde or 20 mg of apomorphine.
Medication was kept stable at least 2 months before surgery.
Statistical analysis
Data, which approximated a normal distribution, are presented as mean values ±
SDs. Changes between pre-operative baseline, 3-month, and long-term fol-
low-up were analyzed using the paired Student t-test. This was repeated for both
states (off and on state) in each clinical parameter. A probability value less than
0.05 is considered to be statistically significant. All were analyzed by SPSS-pc,
version 11.0.1 (SPSS inc., Chicago, 111., U.S.A.).
RESULTS
Thirty-two patients met the selection criteria and underwent bilateral STN HFS.
Five patients died before 4 year follow-up was reached. One patient became stu-
porous after di.ithermia was used on his back musculature, and died soon after-
wards, 1 year postoperatively. CT-images revealed a brain stem infarction. One
patient committed suicide one year after surgery. The other 3 patients died due to
causes clearly not related to surgery. Seven patients were followed by their local
N neurologist, and are excluded from this study since we have no data with the
g_ stimulators being switched off.
Twenty patients (15 men, 5 women) were included in this study. Their mean age
at time of surgery was 60.9 ± 8.3 years (range 45-76 years). Patient profiles are
listed in Table 1. Surgery was started at the side opposite to the most affected side
(in 8 patients at the right hemisphere). At this side, the amount of trajectories nec-
essary to obtain the optimal result varied between 1 and 5, with a mean of 1.7 ±
1.0. At the second side, the amount of trajectories varied between 1 and 4, with a
mean of 1.5 ± 0.83. The final coordinates are listed in Table 2.
Table 3 shows the UPPRS II (ADL). UPDRS III (motor score), UPDRS IVa
(dyskinesias), UPDRS IVb (motor fluctuations), and the Schwab and England
scores, in the off and on state, preoperatively (baseline) and at 3 months fol-
low-up. At long- term (mean 53.6 ±2.6 months), the same scores were assessed in
the same conditions, when both stimulators were on, and when both stimulators
were switched off for 12 hours.
Overall effect on motor function (UPDRS III)
At 3 months, significant improvements were found in the total UPDRS III score,
in the offstate (from 42.3 ± 0.3 to 10.5 ± 6.4). as well as in the on state (from 18.6 ±
12.2 to 10.1 ± 5.9). All motor subscores improved significantly in the offstate
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Table 1 Ounrtenstm ol'ihc 20 panents receiving bibtenl STN.
Charactentac
Sex (no of patients)
male
female
Age (yn ) « «urgery
mean±Sl>
range
Disease duration (yn)
mean ± SI)
range
Mou affected tide
left
nght
Follow-Up (mot)
mean ± SO
range
15
5
60.9 + 8.3
45-76
15 0 + 4.4
10-22
8
12
53.6 ± 2.6
49-58
Table 2 Coordinate* of the final electrode in reference lo the AC-PC line in 20 patient* who received bibl-
cr.il siiniiiliiion of the STN.
DIM.UU c I» mid AC-PC Number of patients
R i g h t I '••"
X: 13 nun be 1 d«>) 2 <«•-")
Y: 0 mm post
Z: 4 mm inf
X: 13 mm lat 1 W I (•»)
Y: 2 mm post
Z: 4 mm inf
X: 11 mm bt I (2)
Y: 0 mm post • •
Z: 2 mm inf
X: II mm lat 1 (3) •» (3.14. U.. 18)
Y: 2 nun post
Z: 4 mm inf
X: I I mm lat 12 (1.4.6.7.12.13. 10 (2.5.6.7.10.
Y: 0 mm pott 14.15,17.18.19.20) 11,13.15.17.19)
Z: 4 mm inf
X: 11 mm bt 1 (5)
Y: (I nun post
Z: 6 mm inf
X: 10 mm lat 3 (8.10.11) 3 (1.9,12)
Y: 0 mm post
Z. 4 mm inf
AC=antcnor commissure; PC=po«enor comituwure; lat=bleral. pott=pottenor. ml md-ri-n. l td ween
brackets, patient numbers arc given
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TabfJ 3 Outcome scores and medication in 20 patients who received bilateral stimulation or" the STN.
Scoring Factor
OFF
UPDRS II
UPDRS III total
tremor
rigidity
akinesia
bradykinesia
freezing
gait
Schwab & England
O N
UPDRS II
UPDRS III total
tremor
rigidity
akinesia
bradykinesia
freezing
gait
Schwab & England
UPDRS IVa
UPDRS IVb
MEDICATION
LED (mg)
Baseline
23.9 ± 7.2
42.3 ± 9.3
4.2 + 4.5
9.1 ± 3.3
15.0 ±4.9
3.1 ±0.8
2.6 ± 0.9
2.8 ± 0.8
23.0 ± 11.7
9.1 ±5.3
18.6 ± 12.1
1.3 ± 2.6
3.0 ± 3.3
6.5 ± 4.8
0.4 ± 0.6
0.7 ± 0.7
0.6 ± 0.8
65.8 ± 9.3
1.9 ± 1.8
3.7 ± 1.3
1133 ± 383
3 months follow-up
SnmON
Score
12.6 + 5.2
19.5 ± 6.4
0.7 + 1.1
1.7 ± 2.1
7.7 ± 3.9
1.5 ±0.6
1.0 ± 0.7
1.4 ±0.7
64.5+ 10.1
4.6 + 2.4
10.1 ± 5.9
0.2 + 0.7
1.7 ± 2.1
3.9 ± 2.6
0.4 ± 0.6
0.4 ± 0.5
0.4 ± 0.5
72.3 ± 6.6
0.4 ± 0.8
0.7 ± 1.1
439 + 237
%
-47.3
-54.0
-83.0
-81.0
-48.7
-51.6
-61.5
-50.0
-49.5
-45.7
-84.6
-43.3
-40.0
0.0
-42.9
-33.3
-79.0
-81.0
61.3
p Value
0.004
<0.001
0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.023
0.002
0.063
0.046
0.007
1.000
0.083
0.171
«>.001
0.004
<0.001
<0.0()l
Long-term follow-up
Snm OFF
Score
Not evaluated
53.6 ± 20.6
4.3 ± 4.7
9 0 ± 4 5
20.1 ±9.3
2.6 ± 1.3
1.7+ 1.8
3.1 ± 1.1
Not evaluated
Not evaluated
38.3 ± 18.5
4.0 ± 5.5
6.1 ± 6.0
15.7 ± 8.6
2.2 + 1.4
1.8+1.6
2.5 ± 1.3
Not evaluated
+20.0
+2.0
-1.0
+25.4
-16.1
-34.6
+9.7
+51.3
+67.5
+50.8
+58.6
+81.8
+61.1
+76.0
p Value
0.160
0.689
0.617
0.070
0.216
0.190
0.090
0.001
0.039
0.091
0.003
<0.001
0.029
0.001
Snm ON
Score
9.7 + 4.0
24.2 ± 13.2
1.7 ±3.9
2.5 ± 3.3
11.2 ± 5.9
1.9 ± 1.5
1.2 ± 1.1
1.8+ 1.2
62.3 ± 14 1
3.9 + 2.0
14.4 ±7.5
0.2 ± 0.7
1.1 ± 1.8
6.9 ± 5.0
0.4 ± 0.5
0.5 ± 0.8
1.3 ± 1.2
74.0 + 9.6
0.4 ± 0.9
0.8 ± 1.1
598 ± 413
%
-59.4
-43.0
-60.0
-73.0
-25.3
-38.7
-53.8
-35.7
-57.1
-22.6
-84.6
-633
+5.8
0.0
-28.6
+53.8
-79.0
-78.4
47.2
p Value
0.004
<0.001
0.039
<0.001
0.046
0.015
0.013
0.002
<0.001
0.040
0.162
0.079
0.030
0.961
1.000
0.546
0.039
<0.001
0.009
<0.001
0.023
Values are expressed as means ± SD; %=change in %(+:increase,-:decrease) with respect to baseline
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with a p<0.001 for rigidity, akinesia. bradykinesia. free/ing and gait, and p=0.001
for tremor. In the on state, however, the only motor subscores in which signifi-
cant changes (p < 0.05) were seen, were rigidity and akinesia. The UI'DRS IV a
(dyskinesias) decreased significantly (p = 0.004) (from 1.9 ± 1.8 to 0.4 ± 0.8), as
well as the UFDRS IV b (motor fluctuations) (from 3.7 ± 1.3 to 0.7 ±1.1)
(p<0.001).
At long-term follow-up review, there were still significant improvements in the
total UI'DRS III motor score (from 42.3 ± 9.3 to 24.2 ± 13.2). as well as m all
motor subscores, in the otf state, during stimulation, albeit slightly less pro-
nounced compared to the 3 months values. In the on state, the only significant
improvement was seen m rigidity (from 3.0 ± 3.3 to I.I ± 1.8). For the total
UI'DRS HI score, as well as tor all other subscores, improvements were not sig-
nificant. In gait, there even was a significant increase (from 0.6 ±0.8 to 1.3 ± 1.2).
When both stimulators were switched oil", there was an insignificant increase in
the total UI'DRS III score in the oil"state. In the on state, there was a significant
increase in the total Ul'I )RS 111 score, as well as in all subscores except for rigidity,
when the stimulators were off. The UIM )RS IV a and IV b scores decreased signif-
icantly (from 1.9± 1.8to0.4±0.9,andfrom3.7± 1.3to().8± 1.1,respectively).
Effect on activities of daily living (UI'DRS II), and Schwab and
England scores
At 3 months, there was a significant decrease in the UI'DRS II score during
chronic stimulation, in the offstate (from 23.9 ± 7.2 to 12.6 ± 5.2), as wel as in the
on state (from 9.1 ± 5.3 to 4.6 ± 2.4). Also at long-term follow-up, decreases were
significant in the offstate (from 23.9 ± 7.2 to 9.7 ± 4.0), as well as in the on state
(from 9.1 ±5.3 to3.9±2.0). The respective scores were significantly (p<0.001)
lower at long tenn than at 3 months (9.7 ± 4.0 compared to 12.6 ± 5.2 in the off
state, and 3.9 ± 2.0 compared to 4.6 ± 2.4 in the on state).
The Schwab and England scores increased significantly in the off state, at 3
months follow-up (from 23.0 ±11.7% to 64.5 ± 10.1%) and at long- term fol-
low-up (from 23.0 ± 11.7% to 62.3 ± 14.1 %), as well as in the on state (from 65.8 ±
9.3% to 72.3 ± 6.6% at 3 months, and to 74.0 ± 9.6% at long term).
Side effects and complications
All patients reported weight gain which was most pronounced during the first
postoperative year (min 3, max 11 kg). In none of the patients epileptic attacks,
intracranial hemorhages or infections occurred. Eight patients were confused
immediately postoperatively. Seven of them recovered after 2 to 3 days. In one
patient (a man, 67- yrs-old), this confused state lasted for 3 weeks. In four patients
there was a worsening of speech (reduced volume), when the stimulators were
on, compared to the stimulation offcondition, at long term. One patient suffered
from blefarospasms, clearly related to the stimulation. He refused any treatment.
Four patients (all men) presented with hypomanic to manic characteristics. In
three of them this became apparent soon after discharge from the hospital. In two
of them hyperactivity and verbal aggressiveness were the main symptoms. One
patient started to spend an exuberant amount of money. This was however in
proportion to his budget, and the psychiatrist judged it to be a "normal" euphoric
state, i.e. in proportion to his improved clinical condition. In one patient, changes
in behavior were seen only after 1 year. This patient exhibited hypersexuality and
started to steel money from his wife for prostitution. Evaluations by a psychologist
blinded to variations in voltage bilaterally revealed that these effects were related
to stimul.ition.
Stimulation parameters
} At long-term follow-up review, stimulation was bipolar in 14 patients at the rightside, and in 16 at the left. At 3 months, the mean voltage was 1.8 ± 0.6 V right and
1.9 ±0.9 V left, with a mean puls width of 333.2 ± 126.8 usec right and 288.7 ±
42 139.7usec left, and frequency 134.5± 14.0 Hz right, and 141.6 ±23.0 Hz lett. At
long term, the mean voltage was 2.6 ± 0.8 V right and 2.6 ±0.9 V left, with a mean
pulse width of 169.3 ± 62.9 usec right and 177.7 ± 90.6 usec left and frequency
133.4 ± 13.8 Hz right and 136.9 ± 18.8 Hz left.
Medication
The Llil) decreased significantly with 61.3% at 3 months (from 1133 ± 383 ing to
439 ± 237 ing), and with 47.2% at long term (from 1133 ± 383 mg to 598 ± 413
mg).
Pulse generator's lite duration
Pulse generators had to be changed because of end of life in 22 of 40 implanta-
tions, after a mean follow-up of 44.8 ± 14.1 months.
Table 4 Results of bilateral STN stimulation in I'D.
Reference
LnnouMii et a l " '
N EnglJ Med, 1V9H
Patients
(no.)
20
F-U
(mos)
12
Results
UPDRS II off:
UI'DRS III off:
UI'PRS III on:
-60%
-60%
-10%
Dvskinesias: -6(>%
Complications
Fraix et jl
Neurology. 2000
Volknunn et J*-
Neurologv. 2lH)l
Krause et al"
INNP. 2O0I
Linotte et J '*
JNNP. » t i l
Sunum et al^*
J Neurose. 2002
24
16
12
12
12
14
12
12
12
UPDRS III off: -68%
UPDRS III on: 16%
IXskincsias: -93%
UI'DRS III off: -67%
UPDRS III on "link change»"
UPDRS II 26%
UPDRS III off: "«at. sign, improvement"
UPDRS III on "no ggn. change'
l>vskinesias: 5«%
Fluctuations: 64*S>
UPORS II off: 55%
UPDRS III off 59%
Pvskinesuv 73%
UPDRS III off -47%
UPDRS III on -2%
I: intracerebral henulonu with
penntent parah^s and aphasia
1: infection (pukgenerator and extension
removed for (> mos)
H transient changes in mental sutus
5 e\ehd-opening apraxia
1 worsening of hypophonu and
postural instability
IX weight gain (mean 4.2 kg)
transient abuha: common
transient anhedonia: common
mild hypophonu: common
mild hvprruhvaoon common
2 infection
I: leaddnlodgcmciK
1 lead fracture
I intracerebral henutoma
1: strong increase in Undo
other mild sum related ode eflectt
50%
(levodopa)
1 defayrd cfacmc «iMiiral H-fead
uifetcuoa n
1 subcorticall
(levodopa)
34S
55%
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Table 4
Reference
Continued.
Patients
(no.)
F-U
(mos)
Results
UPDRS tV: -64%
Vesper et al*' 38
Surg Neurol, 2002
Ostergaard ct al'
Mov Dis. 2002
Thobois et al-''
J Neurol, 2IK)2
26
Spottke ct al-7 16
J Neural, 2W2
Vingerhoets et aP ' 19
Neurology, 2(H)2
14
12 UPDRS II off: 38%
UPDSRS III off: 48%
UDRS III on: 39%
UPDRS IV off: 58%
UPDRS IV on: 72%
12 UPDRS III off: -64%
Dyskinesia duration: -86%
Motor fluctuations: 79%
12 UPDRS II off: 46%
UPDRS II on: 31%
UPDRS III off: 66%
UPDRS III on: 31%
UPDRS IV: 86%
12 UPDRS II off: -37%
UPDRS III off: -45%
Dyskinesias: -92%
Fluctuations: -95%
12 UPDRS II off: -52.8%
UPDRS III off: -55%
UPDRS IV: -76%
Complications Medication
reduction
1: single generalized seizure
1: infection of battery- (removed)
1: transient change in mental status
2: infection (system removal)
2: worsening of preop depression/dementia
no serious side effects
2: weight gain>2 kg
transient and usually mild
3: acute agitation (transient)
3: depression
2: lower limb phlebitis
I: pulmonary embolism
6: depression
1: dysarthna and freezing
1: sialorrhea and drooling
53%
(levodopa)
22%
(LED)
51%
(levodopa)
79%
(LED)
65.5%
(LED)
Table 4 Continued.
Reference Patients
(no.)
F-U
(mos)
Results Complications Medication
reduction
Romitoetal-* 22 12 UPDRS II off:-48.2%
Neurology. 2002 UPDRS HI off: -50.2%
1: postural unbalance
weight gain in all pts (average* 12.4%)
4: transient hypersexuality
2: transient numc psychosis
1: seizure
4: hypophoma
4: hypophoma and dysarthria
4: eye lid opening apraxu
2: worsening of depression
2: psychic alunesu
1: limb dystoma
1: bilateral buccinator spasm
7: short-lasting psychosis
1: lead migration
1SAH
3: unexplained switching off of device
2: sudden end of battery
65. H%
(LED)
OB
r
3.
I
-
5
3.
0
3
2.
§
o
3
on: on - medication
off: off- medication
NUI sutisticallv
sign significant
pts : patients.
n in not mentioned: H: henutoma
SAH surunchnoidal hemorrhage
DISCUSSION
This study showed that there was a significant effect of bilateral STN stimulation
on ADL (UPDRS II) and motor function (UPDRS III) in the off state, at 3
months and at 4 year follow-up review. The positive effect on motor function
was significant for the total UPDRS III score, as well as for all the subscores
(tremor, rigidity, akinesia, bradykinesia, freezing and gait). The effect on ADL
was significantly better at long term compared to the score at 3 months. The effect
on motor functions (total score as well as all subscores), seemed to be less pro-
nounced at long term than at 3 months. All these changes in effects between short
and long-term evaluations were, however, not statistically significant.
In the on state, the effect on ADL was again clearly pronounced at 3 months and at
long term, with a significantly better effect at long term. The increase in the
UI'DRS III motor score, and the increase in the rigidity subscore at long term,
compared with the 3 months scores, was not statistically significant. The tremor
and bmdykinesia subscores remained the same. For akinesia, freezing and gait the
effect seemed to be worse at long term than at 3 months. This was however only
significant for akinesia and gait. The gait subscore was even higher than baseline.
The effects on the UPDRS IV a and IV b were significant, and stable, at 3 months
.iiul .it long term (the difference in
with long term is not significant).
 UPDRS IV b values at 3 months compared40
All ratings were performed by two unblinded investigators, with the patient also
being unblinded. It has been discussed before that in blinded studies patients as
well as investigators are often aware of the on or off state of the stimulation
because of the symptom relief experienced by the stimulation or because of symp-
toms that occur at the onset of stimulation, like paresthesias-''.
These results are comparable with other studies with long-term follow-up. Table
4 shows the results of the effects of bilateral STN stimulation in advanced PD in
studies with a minimum often patients and a minimum follow-up of 1 year for all
patients. The average decrease on the UPDRS III is 52% in the off state. The
UI'DRS II off score decreases with an average ot 42%. Dyskinesias and motor
fluctuations improve with an average of77%. The decrease on the UPDRS III on
is better in our study (45.7%, vs an average of 26%). This may be due to a differ-
ence in postoperative medication reduction. In this study medication could be
reduced at 3 months by 6! .3%. and at long term by 47.2 %. The change in LED
reduction at 3 months and at long term is not statistically significant. The average
medication reduction in the studies described in Table 4, is 57%.
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In this study depth recordings were not used during the stereotactic procedure. In
a search for better targeting and thus tor better results, we have implemented
semi-microelectrode recordings after this study, and unproved our target imag-
ing by fusing CT-, and MR- images. We are, however, well aware of the tact
that the potential advantages (better targeting) and disadvantages (more tracks
leading to more bleedings) ot depth recordings are still under discussion and have
not yet been statistically evaluated in comparative studies.
The increase in voltage from 3 months follow-up to long-term follow-up (from
1.810.6 V to 2.6 ±0.8 Vat the nght side, and from t.9±0.') V to2.6±0.V Vatthe
left), is counteracted by the decrease in pulse width (from 333.2 ± 126.8 usec to
169.3 ± 63.0 u-sec at the nght. and from 288.7 ± 13<>7 usec to 177.7 ± «)0.6 u-sec at
the left). It was our policy to reduce pulse widths in the postoperative course of
these patients in order to become a more selective effect of stimulation, and thus
reduce stimulation induced side effects (mainly speech disturbances and behav-
ioral changes).
The less obvious effect on the UIM)RS III in the on state can be, at least partially,
explained by the significant increase in the subscores for akinesia and gait com-
pared to the 3 months scores, with even an increase in the gait subscore compared
with the baseline score. The difference in effect on the Ul'l )RS II compared with
the UPDRS III score is even more pronounced in the on state than in the off state.
One possible explanation might be the marked reduction in dyskinesias, which
make patients function better during ADL in the on state. C )n the other hand, the
decrease in effect on UPDRS III on, can be explained by progression of symp-
toms that are not responsive to levodopa, like balance disturbances.
The insignificant change in the UI'DRS scores after 4 years when both stimula-
tors were switched off, compared with the baseline scores, might be suggestive for
a previously hypothesized neuroprotective effect ot bilateral SIN stimulation^.
Nigrostriatal degeneration, which occurs in I'D, leads to a electrical hyperactivity
of the STN. The dopaminergic part of the substantia nigra (SNc) receives an
excitatory input from the STN. This raised the possibility of NMDA-mediatcd
excitotoxic damage to the substantia nigra, pars compacta, as a result ot STN
hyperactivity. It has been hypothezised through animal studies that "silencing"
the STN by HFS, could lead to slowing or even stopping the disease progres-
sion^'''"*'. Upto now, however, no clear clinical evidence has become available
supporting this hypothesis.
This study confirms that the implantation of electrodes in the brain is a safe proce-
dure. The stimulation induced behavioral changes, however, need special con-
sideration. In this study personality changes were obvious in four patients. In one
of them, hypomania with hypersexuality became apparent only one year after
surgery. This was not preceeded by a change in medication or stimulation param-
eters. One patient with bilateral STN stimulation for advanced PD was not
included in this study because he committed suicide before 4 year follow-up was
reached. Of the 221 patients described in Table 4 (the study of Lanotte et al not
included, since complications were not mentioned), ten presented with persis-
tent changes in mental and/or psychic functioning. More and more reports
appear with special focus on the effects on mood of bilateral STN stimula-
tjon*-s.»/».io.i2.i8.23.25.29_ 5j[yj stimulation seems to induce euphoria, an increase
in motivation, and a decrease in fatigue, anxiety, and tension. Although this effect
might be partly secundary to the improved motor-function, PET-studies have
shown that STN stiinulation directly influences limbic related structures like the
anterior ungulate gyms' \ Moreover, acute effects on mood with mirthful laugh-
ter related to STN I )BS have been described that can not be explained by a change
in motor function'". After STN DBS, not only euphoric states, but also depres-
sion is described. Depression after STN DBS might due to three factors. First, it
might be caused by the postoperative decrease in levodopa which is known to
M have a psychotrophic effect. Second, a direct influence of STN DBS on limbic
} related structures might be responsible, or, current spread to neighbouring struc-
tures, like the substantia nigra. The difficulty of these mood changes is that they go
mostly hand in hand with the positive motor effect: in several patients (all
hypomanic) we tried to change stimulation parameters to maintain the motor
benefit and avoid behavioral changes, but these attempts were always unsuccess-
ful. The disappearance of the behavioral changes were probably not secondary to
the motor deterioration, since only acute effects were tested, and the after effect
for motor function after the stimulators were switched off, was longer than the
after effect for behavior.
C:ONCl.USION
The conclusion of this study is triple. First, the beneficial effects of bilateral STN
stiinulation on motor function (UPDRS III), and ADL (UPDRS II), is main-
tained after tour year follow-up. Second, these positive effects can be obtained by
.i relatively simple technical procedure, with target determination on CT-images,
without depth-recordings. Third, stimulation induced behavioral changes after
STN DBS need special consideration. They may occur late in the postoperative
course.
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CHAPTER 3
Bilateral high-trequency stimulation of the
subthalamic nucleus in patients with multiple
system atrophy-parkinsonism
A report of four cases
Veerle Visser-Vandcwallc, Yasin Temcl. Henry Colic,
Chris van der Linden
2-tf«7.2OÖ.J
Abstract
The aim of this study was to investigate the effect of high-frequency stimulation
(HFS) of the subthalamic nucleus (STN) in patients with a subtype of multiple
system atrophy (MSA) in which levodopa-unresponsive MSA parkinsonism
(MSA-P) is predominant.
After a local anesthetic was administered, electrodes were stereotactically im-
planted bilaterally into the STN in four patients with MSA-P and predominantly
akinetongul symptoms. Unified Parkinson's Disease Rating Stale (UPDRS)
scores were ev.ilu.ilcd preoperjtively, at 1 month, and ,>t long-term follow-up.
*2 At I month the median decrease in the UPDRS III motor score was 22 on the
S. 56-point scale (decreases of 16, 13, 2V, and IS points compared with baseline for
3
(j Cases I, 2, 3, and 4, respectively). This was mainly due to an improvement in ri-
"77 gidity and akincsia. The median decrease in the UPDRS II score was I 1 on the
52-point scale (respective decreases of 5, 7, 13, and 9 points). At 2 years (mean
follow-up 27 months) there was a median decrease in the UPDRS III score of 12
(respective decreases of IS, 13, 21 and ') points), and in the Ul'DRS II score of 5
(with respective decreases of 2, 2, 17, and 2), both compared with the stimulation
off state.
At long-term follow-up there was an increase in the individual Schwab and Eng-
land scores of 10 to 15% in the stimulation on compared with the stimulation ofF
condition.
There was a beneficial effect of STN HFS in these four patients on both a
short-term and a long-term basis. A larger prospective study is justified.
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Multiple system atrophy is an adult-onset neurodegenerative disease of unknown
origin. It causes parkinsonun. cerebellar, pyramidal, and autonomic/urinary
dysfunctions in many combinations, leading to different clinical subtypes'. The
discovers- in 1989 of ghal cytoplasniic inclusions in the brains of patients with
MSA provided a neuropathological marker and continued that MSA is a single
clinicopathological entity^. In the majority of cases, levodopa-unresponsive
parkinsontsm is the key clinical feature in what is known as the MSA-P subtype.
Although considered a rare disease, MSA-P may account for up to 10"» of patients
with parkmsonism'* and is one of the most common conditions mistaken tor PI).
In addition to a poor or absent levodopa response, clinical signs of MSA-P include
symmetrical onset of symptoms, relative absence of rest tremor, early instability,
and rapid disease progression'.
In contrast to PI), in which there is a purely presynaptic dopanunergic neuronal
cell loss, in MSA the degeneration is pre- and postsynaptic'-. Progressive loss of
stnatal postsynaptic dopamine I)i receptors is thought to account for levodopa
unresponsiveness. An IBZM-SPECT scan can be used to differentiate between
MSA-P and I'D because it detects a significant loss of striatal dopamine recep-
tors.^ "
This study presents the short- and long-term effects of bilateral STN stimulation
on the symptoms of four patients with MSA-P who were unresponsive to
levodopa treatment.
CLINICAL MATERIAL AND METHODS
Patient population
Patients were selected based on having poor levodopa responsive p.irkinsoinsm of
unknown origin, combined with autonomic failure including urinary dysfunc-
tion (probable MSA according to the consensus criteria'') and severity of disease
(Hoehn and Yahr' stage >3 and <5 in the best condition). The levodopa response
was defined as poor when the improvement in the UPI )RS III motor score was
less than 5% in patients undergoing antiparkinsonain drug therapy (levodopa plus
decarboxylase inhibitor up to 1 (MM) mg / day and pergolide given for >3 months).
We diagnosed autonomic dysfunctions on the basis of anamnestic data.
Orthostatic hypotension was diagnosed on the basis of a symptomatic postural fall
in systolic blood pressure ot 30 mm Hg within 3 minutes of standing upright from
the recumbent position. Exclusion criterion for STN HFS was mental dysfunc-
tion. Patients with poor cardiovascular or pulmonary status or those receiving
anticoagulant therapy were also excluded.
All patients underwent IBZM-SPECT scanning when the diagnosis of MSA-P
was suspected on clinical grounds. Only patients with a significant decrease in
striatal postsynaptic dopamine receptors were included. Patients in whom struc-
tural abnormalities were demonstrated on the MR image (including severe
supra- or infratentorial atrophy) were excluded.
None of the patients received antiparkinsonian medication for at least 2 months
prior to surgery.
The study was approved by the institutional review boards from both hospitals
and informed consent was obtained from each participant.
Clinical assessment
Activities of daily living (AI)L) and motor function were studied using the
^ UPI )RS Parts II .»id IIP. Maximum scores (52 for UPDRS Part II and 56 for
fc UPI )RS Part III) reflect the worst clinical condition. The severity of the disease
jS was assessed using Hoehn and Yahr staging^ (raging from 0, no signs of disease, to
^ 5, wheelchair bound or bedridden unless aided). The level of dependency for
54 Al )L was evaluated by means of the Schwab and England Scale-' (0% is worst and
100% is best). All postoperative assessments were conducted by two independent
investigators who, postoperatively, were blinded for stimulation. Postoperative
evaluations were performed when the stimulation was on, and 12 hours off, 1
month postoperatively, and at the long-term follow-up evaluation.
Operative procedure
The entire procedure was performed using stereotaxy while the patient received a
local anesthetic. For patients undergoing surgery at the University Hospital of
Ghent, the I.eksell G stereotactic frame was used and stereotactic coordinates
were determined based on C T scanning. For the other patients undergoing sur-
gery at the St. Lucas Hospital in Ghent, the Cosman Roberts Wells stereotactic
frame was used and the coordinates were determined based on fused C T and M R
images. The target was defined in the dorsolateral part of the STN.
The following coordinates were used in reference to the A C - P C : 11-12 mm lat-
eral to the A C - P C , mid A C - P C , and 4 mm beneath the A C - P C . The angle of
approach was chosen to be as perpendicular as possible to both coronal and sagittal
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planes, thereby avoiding the lateral ventricle. We began surgery on the right side
in all patients. No micro- or semimicroelectrode recording was used. A 2-imn
monopolar test electrode with a naked tip (model 3101-2; Radionics,
Burlington. MA) was introduced 6 mm above the target and stimulation began at
a frequency ot UM) Hz and a stimulus duration ot 100 usec. The stimulus intensity
was increased in 0.5 V stages to the desired response or until untoward side ertects
occurred. Stepwise test stimulation was continued in 2 nun steps to 4 mm beneath
the target. At each point ot'test stimulation the clinical response w as evaluated by
one neurologist (C.v.d.L.) blinded during the stimulation. The follow ing clinical
parameters were scored using the UPDRS: rigidity in all four extremities (must
be diminished by 2:2 points on the U1M )RS), finger tapping, opening and closing
of the hands, and tlexion-extension of the leg. When a beneficial ctVcct was found
without side effects, the test electrode was replaced by the final quadripolar elec-
trode (model 3389; Medtronic), placing the second deepest pole (Polo 1) at the
level ofthe best clinical response in the patients in ("ases 1.3 and 4. and the deepest
pole (Pole 0) at the level ofthe best clinical response in the patient in C !ase 2. In all
patients one trajectory on each side was sufficient to achieve a good clinical effect.
The position of this final electrode was checked using fluoroscopy. Phis electrode
was fixed in the burr hole with acrylic cement and connected to an externalized
extension cable. The same procedure w as then performed on the loft side in each
patient.
After this first operation, the four patients were tested using externalized elec-
trodes connected to a screener (model 3625; Medtronic) for approximately I
week to evaluate responses based on UPI )RS Parts II and III ! I> all patients a post-
operative MR image revealed that the electrodes were positioned well without
any bleeding. Once agreement was reached among the neurologist, neurosur-
geon and nursing staff on clinical improvement ofthe patient, we performed a
second operation approximately 1 week later to implant two pulse generators
infradavicularly (Itrel III, model 7425; Medtronic).
Statistical comparisons
Comparisons were performed using the Friedman test, for ik related comparisons,
and the Wilcoxon signed-rank test for two related comparisons for paired
nonparametric data. The level of significance was accepted at a probability value
less than 0.05.
RESULTS
Four patients were included in this study (one man and three women, age range
59-66 years at the time of surgery). Patient profiles and clinical characteristics are
shown in Table 1. All patients suffered from a severe akineto-rigid syndrome with
gait ataxia. In three patients the gait abnormality was partly extrapyramidal (slow
shuffling short steps, hasteningsteps, and propulsion), and partly cerebellar (irreg-
ular timing, irregular direction, and irregular length of steps). The patient in Case
4 had a predominantly extrapyramidal gait. No patient had tremor.
The patient in Case 3 died of pneumonia after 6-month follow- up. The other
patients were followed for at least 2 years (29, 28 and 44 months for Cases 1,2 and
4, respectively).
Tabl« 1 Demographic features and clinical characteristics in four patients.
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Motor examination: UPDRS Part III
After 1 month of chronic stimulation, the total UPDRS III motor score clearly
decreased in all patients (Case 1: from 32 to 16; Case 2: from 55 to 42; Case 3: from
49 to 20; Case 4: from 42 to 27), with a significant (p<0.05) change in the median
score of 22 (Table 2). This was mainly due to improvements in rigidity (Case 1:
from 10 to 4; Case 2: from 15to 10; Case 3: from 14to 1; Case 4: from 5 to 2), and
akinesia (Case 1: from 16 to 4; Case 2: from 23 to 20; Case 3: from 18 to 8; Case 4:
from 19 to 13). Bradykinesia improved in Cases 2, 3 and 4 (from 3 to 2 in each).
For the patient in Case 1, who had a low preoperative score (1), there was no
change after 1 month of stimulation. There was gait only improvement in Cases
2, 3 and 4 (from 3 to 2, from 2 to 1, and from 3 to 2, respectively). For the patient
in Case 1, who also had a low preoperative score for gait (1), there was no change.
At long-term follow-up, there was an increase in the UPDRS Part III total score
when the stimulators were switched off, in the patients with a follow-up of more
than 2 years (Case 1: from 32 to 63; Case 2: from 55 to 60; Case 4: from 42 to 46).
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Table 2 Individual and median scores on me UPDRS Pans II and III m lour patients with MSA-P who
received büateral STN stimulation
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15
16
21
4
3
3
3
3
3
3
2
4
3
3
3
2
4
3
Stim ON
.44
35
20
29
31 5*
45
47
2«
37
41*
4
7
0
2
3*
19
23
9
II
15*
3
3
2
2
2.5
3
3
1
4
3
3
2
2
4
2 S
* Change in scores
lators off
was significant (p<0.05) with both stimulators on. compared with scores with both «mm-
Table 3 Individual Schwab and England ADL and Hoehn and Yahr scorn in four patients who received
bilateral STN stimulation.
Scoring factor
AOL SCOT«
Catc 1
Ca»e2
Case 3
Case 4
H & Y Sta^e
Case 1
Case 2
Case 3
Ca«e 4
Baseline
60%
50%
65%
60%
3
4
3
3
1-mo follow-up
StimOFF
60%
50%
65%
60%
3
4
3
3
= Stim ON
80%
75%
80%
75%
2
3
2
2
Long-term
Stim OFF
20%
15%
65%
25%
5
5
3
5
follow-up
Stim ON
30%
25%
80%
35%
5
5
2
5
In all patients this score clearly decreased when the stimulators were switched on
(Case 1: from 63 to 45; Case 2: from 60 to 47; Case 3: from 41 to 20; Case 4: from
46 to 37), with a significant (p<0.05) change in the median score of 12. In all
patients there was a decrease in the scores for rigidity (Case 1: from 14 to 4; Case 2:
from 16 to 7; Case 3: from H to 0; Case 4: from 4 to 2) and akinesia (Case 1: from 26
*j) to I'J; Case 2: from 27 to 23; Case 3: from 15 to 9; Case 4: from 16 to 11).
§• Hradykinesia improved in Cases 1, 3 and 4 (from 4 to 3, 3 to 2 and 3 to 2, respec-
ts lively). (Jait only improved in Case 3 (from 2 to 1) and postural stability only
58 improved in Case 2 (from 3 to 2).
Activities of daily living: UPDR.S Part II
At 1-month follow-up, the U P D R S Part II score decreased in all patients with
stimulators turned on (Case 1: from 19 to 14; Case 2: from 36 to 29; Case 3: from
33 to 20; Case 4: from 25 to 16). At long-term follow-up, only the patient with
the shortest follow-up (Case 3) showed a clear decrease when the stimulator on
scores were compared to the stimulator off scores (from 37 to 20).
Hoehn and Yahr scores
After 1 month of stimulation the individual Hoehn and Yahr scores decreased by
1 point for each patient (Table 3).
At long-term follow-up, only Case 3 showed a decrease of 1 point with the stimu-
lators turned on (from 3 to 2, at 1 month and at 6 months). For the other three
patients the score remained at 5.
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Tabal 4 lndivvJuil mmulinon characteristics in four pjticnn who received tuUieral STN «mnuUnon *
Case
No.
I
2
3
4
Electrode
settings
1-. 3+
1-, Case +
1-, Case +
2-. 3-. Ca*
Frequency
130
130
130
+ 130
Amphrude (V)
1 Mo
Right
2S
2.7
2.0
1.8
FU
Left
2S
2.7
24
1.8
L T K
Right
22
28
24
20
Lett
2.4
3.0
28
24
r\ilv
1 M.
R*l>
210
210
210
270
Width <ii>e
. ir
,i i .-ti
JIO
210
210
210
l i i r
Ri^l.i
JIO
210
210
210
l.eli
210
210
210
210
FU= to|jow-up; LT=k>njc-terni
Schwab and England scale
After 1 month of stimulation the preoperative ADL scores remained the same
when both stimulators were switched off (60, 50, 65, and 60% for Cases I, 2, 3,
and 4, respectively). With the stimulation on. the scores increased by 15 to 25%
(with scores of 80, 75, 80 and 75% for Cases I, 2, 3, and 4. respectively). The
scores decreased dramatically for the patients with a long-term follow-up of more
than 2 years when both stimulators where switched off (Case 1: from 60 to 20%,
Case 2: from 50 to 15%, Case 4: from 60 to 25%). With the stimulators turned on,
these scores increased by at least 10% (Case 1: from 20 to 30%; Case 2: from 15 to
25%; Case 3: from 65 to 80%; Case 4: from 25 to 35%).
Stimulation characteristics
The iudiviilu.il stimulation parameters, at 1 month and .it long-term follow-up,
are given in Table 4.
Adverse effects
Mild confusion was observed in one patient immediately postoperatively. There
were no other adverse effects such as intracranial bleeding, infections, seizures,
stimulation-related paresthesias, involuntary movements, or changes in behavior.
Side effects
Two patients reported significant weight gain (10 and 13 kg).
Effects on cerebellar signs and autonomic failure
Gait ataxia (locomotor ataxia: irregular timing, irregular direction, and irregular
length of steps), which was clearly present in Cases 1, 2 and 3 preoperatively, was
unaffected bv STN HFS. Subthalamic nucleus HFS also had little effect on
extrapyramidal gait ataxia (slow shuffling short steps, hastening steps, and propul-
sion) and no effect on autonomic failure in these four patients.
DISCUSSION
The results of this study demonstrate a beneficial effect of bilateral STN stimula-
tion on individual total UPDRS Part III scores at 1 month (with a decrease of 16,
13, 29 and 15 points for Cases 1, 2, 3, and 4, respectively, on the maximum score
of 56), and at long-term follow-up when stimulator on scores were compared
with stimulator off scores (decreases of 18, 13, 21 and 9, respectively.). When
UPDRS Part III subscores are considered, the effect is most pronounced for
rigidity and akinesia.
On the UPDRS Part II there was a decrease at 1 month in all patients (decreases of
5, 7, 13 and 9 for all patients, respectively, on the maximum score of 52). At
long-term follow-up, there was a clear improvement only in Case 3 (17 points).
In the other three patients with long-term follow-up of more than 2 years, there
was a decrease of 2 points on the UPDRS Part II.
In all patients there was an improvement on the Hoehn and Yahr score at 1
month. At long-term follow-up, there was no improvement in the three patients
with follow-up longer than 2 years.
In all patients there was an improvement on the Schwab and England ADL score
at I month (15-25%) and at long-term follow-up (10-15%).
There was no change in cerebellar or autonomic dysfunction in any of the
patients.
The main question is whether these results justify further application of this tech-
nique in more patients with MSA-P. We believe they do for a number of reasons.
First of all there is the safety of the technique and the lack of other treatment
options.
There is no proven effective treatment for MSA-P. One-third of patients with
MSA-P show a clinically significant response to levodopa therapy, but this
response usually lasts for fewer than 5 years'*. There is no evidence to endorse
other drug treatment options. Surgery has rarely been performed in patients with
MSA; only two patients with MSA who underwent surgery have been reported
and both underwent HFS of the STN.'^ '"' The first patient'" did not show any
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improvement. The second patient met the clinical criteria tor PD (including
levodopa responsiveness) and showed substantial improvement of motor symp-
toms after STN HFS'''.
In these four patients, bilateral STN stimulation has been shown to be a safe tech-
nique. On a much wider scale, STN HFS has proven to be a good and safe treat-
ment for alleviating parkinsoman motor symptoms in cases of advanced PD-'
3,»-11,15-16.17,23-25
Patients with MSA-P have a relatively short life expectancy: the main disease
duration varies between 6.1 years^" and 9.5 years-*.
Our results demonstrate that the effect of stimulation declines over time, although
the results in Cases 1, 2, and 4 (with follow-up periods of 29, 28 and 44 months,
respectively) show that there still is an effect at this long-term follow-up. The
shorter the disease duration, the more meaningful the effect of treatment at these
follow-up periods. It has also been our experience that the effect of STN stimula-
tion dunng the long term is greatly appreciated by the patient. For patients, a
change of 10% on the Schwab and England Al )I scale is a significant gain. Con-
sidering the natural, progressive evolution of the disease, lor which the scores
with the stimulators off are demonstrative, the Schwab and England AI)! scores
show that the patients are more independent with than without stimulators. Mach
patient found the operation to have been worthwhile considering the
improvement gained.
None of the four patients responded to levodopa therapy. The positive effect of
STN stimulation on motor function (most pronounced for rigidity and akinesia)
might be explained by a mechanism similar to that in PI), in which GPe hypoac-
tivity leads to STN hyperactivity. In PI), loss of dopaminergic cells leads to
enhanced striatal inhibitory outflow towards GPe (indirect pathway), with liypo-
activity of GPe and hyperactivity of the STN as a consequence. Increased excita-
tion of GPi by the STN leads to reduced thalamocortical drive, which is thought
to account for motor symptoms of I'D. Loss of dopamine leads to reduced striatal
inhibitory outflow towards GPi (direct pathway), also leading to hyperactivity of
the GPi, and reduced thalamocortical outflow. In MSA, an autoradiographic
postmortem study suggested that disease progression may initially affect the indi-
rect striatal pathway, and subsequently, with increasing disease duration, the
direct stnatopallidal pathway-'. The degenerative change appears to be more
marked in the Gl'e than in the GPi. Subthalamic degeneration is uncommon and,
if present, rarely severe. This hypothesis of STN hyperactivity due to GPe degen-
eration could explain the (partial) beneficial effect of STN HFS in these four
patients, whereas levodopa therapy had no effect, due to loss of striatal D2
receptors.
The poor effect on postural instability and gait disturbances in these four patients
might be explained by the involvement of cerebellar pathways in the degenera-
tive process of MSA-P that, together with basal ganglia pathways, regulates gait
and balance. Cerebellar and basal ganglia pathways both project to the
motor-related thalamus, upstream from the STN, but remain separated^. Also the
absence of effect on autonomic functions might be explained through degenera-
tion of parts of the central nervous system, not connected to the STN, like the
intermediolateral columns. The absence of effect on cerebellar and autonomic
dysfunctions explains why the effect on UPDRS Part II scores is less pronounced
than on UPDRS Part HI.
C O N C L U S I O N S
Subthalamic nucleus HFS in these four patients with probable MSA-P had a posi-
"2 tive effect on UP1 >RS Part 11 and UPDRS Part III scores. The effect declines over
fr time, but .it long-term follow-up, the patients' motor score and ADL scores were
U still dearly better with stimulation than without. We believe that these resultsjus-
42 tify a larger, prospective study.
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CHAPTER 4
Research Review
Surgery in Tourette Syndrome
Yasm Tcmcl and Veerie Visscr-Vandewalle
Summary
Tourette syndrome (TS) is a neuropsychiatric disorder with onset in early child-
hood. It is characterized by tics and often accompanied by disturbances in behav-
ior, such as obsessive-compulsive disorder (OCD). In most cases, the disorder is
self-limiting or can be treated by medication or behavioral therapy. In a small
percentage, however, symptoms are intractable to any conservative treatment.
Since 1955, various attempts have been made to treat these patients through
T ncurosurgical procedures.
8, The target sites have been diverse and include the frontal lobe (prefrontal lobot-
Q omy ami bimedial frontal leucototny), the limbic system (limbic leucotomy and
~ ~ anterior cingulotomy), the thalainus and the cerebellum. Combined approaches
Ov
have also been tried such as anterior cingulotoiiiies plus infrathalamic lesions. The
results have often been unsatisfactory or major side effects have occurred, such as
hemiplcgia or dystonia.
Our review of the literature from 1960 until 2003 revealed 21 reports and 3 de-
scriptions in textbooks covering about 65 patients in total who had undergone
ablative procedures for intractable TS, the first being reported in 1962. In 1999,
deep brain stimulation (DBS) was introduced as a new approach for intractable
TS. To date, 3 patients have been reported who underwent bilateral thalamic
stimulation, with promising results on tics and, obsessive-compulsive symptoms.
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INTRODUCTION
Tourette Syndrome (TS). named after Georges Albert Edouard Urutus Gilles de
la Tourette, a French neuropsychiatrist (1857-1904)' • -. is a chronic neuropsychi-
atric disorder characterized by the presence of various tics. Tics are sudden, brief,
intermittent, involuntary or semivoluntary movements (motor tics) or sounds
(phonic or vocal tics). Tics usually wax and wane in frequency and intensity dur-
ing the natural course of the disease. At one time, TS was considered a rare syn-
drome. Nowadays, it is recognized as a relatively common disorder. An estimated
worldwide prevalence of 4 to 5 cases per 1(>,(KM) individuals lias been reported \ A
recent study'', however, revealed a prevalence of 31 to 157 cases per I ,(MMl indi-
viduals in 13 to 14 year-old children attending mainstream secondary schools in
the United Kingdom. There is a considerable variation in studies reporting on the
prevalence ofTS, due most probably to variations in gender, age, diagnostic crite-
ria, and assessment methods'*.
Throughout the history of this disorder, a variety of theories have been proposed
concerning its origin including psychogemc. developmental, and inflammatory
mechanisms. Various clinical, neuropathological and neuro-imagiiig observa-
tions suggest that dysfunction of the basal ganglia and related th.il.iiiHHortu.il cir-
cuits form, at least in part, the pathophysiologic.il basis of TS'' '". It is assumed that
the basal ganglia play a major role in the "timing and sequencing" of motor .uul
behavioral programs by selecting desired and suppressing unwanted programs to
be executed"-'-. Uncontrolled movements and vocalizations in TS might be the
result of defective inhibitory mechanisms at the level of the basal ganglia leading
to the expression of simple or more complex motor or behavioral acts. The pri-
mary pathology that leads to the defective selection mechanisms is still unknown.
Intrinsic striatal or extrinsic factors (e.g. excitatory or dopaminergic atFercnts at
the level of the striatum) might play a role' \
The onset of the disease often occurs in childhood with motor and/or vocal tics,
the latter usually beginning several years later^. TS is associated commonly with
symptoms of obsessive-compulsive disorder (O('D) and attention-deficit hyper-
activity disorder (ADHD). Although it is frequently self-limited, some patients
remain symptomatic and require chronic treatment. The standard treatment is
pharmacological involving mainly neuroleptics, a2-adrenergic agonists and
sometimes benzodiazepines. In some cases, behavioral treatment may provide
temporary control of symptoms but certain patients prove to be medically
untreatable or experience unbearable side effects from the medication. It is these
patients who have been potential candidates for neurosurgical interventions.
During the past few decades, many ablative procedures have been carried out in
an attempt to treat intractable TS. In total, 65 patients have undergone ablative
surgery varying from "tailored" stereotactic operations to more rigorous
prefrontal lobotomies, and 3 patients have undergone DBS (see figure 1). In the
present review, the various neurosurgical procedures are described chronologi-
cally together with their outcome, and the present role of surgery in TS is
discussed.
Search strategy
All articles and textbooks containing descriptions of surgery in TS were reviewed.
The reports were found by a Medline search (PubMed) using the key words:
Tourette syndrome, TS, Tourette, Gilles de la Tourette, tic, tics and tic disorder
in combinations with surgery, neurosurgery, surgical intervention, lobotomy,
limbic leucotomy, leucotomy, cingulotomy, campotomy, thalamotomy,
dcntatotomy, coagulation, ablative, ablative surgery, stereotactic, stereotactic
surgery and DBS. Some of the reviewed reports in this article were not Medline
indexed. These were found by analysis of the bibliography of all included
Medline-indexed articles. Only works published in English, German and French
were reviewed.
In total, 21 reports and 3 textbooks were found describing original cases. All data
.inVnu pnevent cn'aractenstic's, medical history, surgery, outcome and side effects
were collected.
ABLATIVE- PROCEDURES
summaries of ablative procedures are shown in Tables 1 and 2
1%1 - 1970
In 1%2, Baker'"* described TS as an "involuntary paroxysmal hyperkinesis
involving entire skeletal musculature" and reported the first leucotomy for TS.
The patient was a 22-year-old man who had had vocal and somatomotor tics since
the age of9 years, with severe obsessive-compulsive behavior (OCB), and " rest-
lessness, irritability, and distractibility". According to the author, the latter could
be associated with brain damage from birth. Pharmacological treatment had no
effect on tics and behavioral symptoms. In October I960, a bimedial leucotomy
was carried out. The procedure was complicated by a frontal lobe abscess, which
was aspirated. After a follow-up of 1 year, the patient presented with minimal tics
and obsessive-compulsive symptoms (OCs), according to the same author.
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Table t Patient charactensoo of 65 patient» who underwent ablative procedure» for intractable Tourer«
Syndrome. _ _ _ _
Reference Patients Ajje at surgery Gender IHsease ImücMion lör sundry
(>T) duration (yr)
Baker"
Cooper'*
Stevens'*
Haaler et _.«»• » • »
Nadvorruk et »!.*'
Becken-'
Moldokky et j j . ö
Wassman et al.-*
Avun et al.2*
Gappabianca et a l .^
Robertion et a l .^
KurUn et »!.•»• 3'
Konen et a l . "
Sawle et a l .^
Lecknun et al.-^
Uaor et a l . "
Rauch et _ » • "
Korzenev et al.">
Habel et a l . "
1
t
2-6
t
1
2
3
4-9
10-15
1
1
2
3
1
1
1
2
1
2
3
4
1
1
2
1
!
1
1
1
2
3
1-4
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
22
16-17-22
n.m.
37
28
n.m.
19
n.m
n.m
12
23
31
35
n.m.
n.m.
14
15
2(1
19
24
23
19
28
17-22
19
45
40
33
34
40
n.m.
n.m.
21
29
28
21
31
34
19
40
11
15
20
23
21
23
26
19
m
f
n.m
m
m
f
m
n.m
n.m
m
f
m
f
m
f
m
m
m
f
m
m
m
m
m
rn
m
m
m
f
m
m
n.m
• • m
f
m
f
f
f
m
f
m
m
m
m
m
m
m
m
13
7
n.m.
29
n.m.
n.m.
10
n.m.
n.m.
n.m.
18
21
28
22
24
S
11
13
9
16
15
14
23
11
14
38
37
30
n.m.
37
n.m.
n.m.
12
16
14
13
23
12
14
33
7
3
9
17
15
19
18
13
tie» and C X ' J
t k s
n.m
tic» and I X J
tu-*
n n
HOS
uc>
tic>
tic»
no and IX'»
tic«
tic» and IX".»
n in
n in
tic»
no
n.m
n.m
tux and IH! t
n in
111 « 4lld ( H'»
In \ and (X'.«
tut and I K ' i
tut and CX'%
tic» and ()('.«
tin and C X \
tics Jiul O( \
ins ami C K'%
no and (X \
tic»
n. in
net
t u t
tic»
tics
tic»
tic»
t i n
t i l l
tic»
tic«
tic». A D H D and (X:»
tic«
tic»
tic». ADHD i m K X j
tin. ADHD and (X;*
tic»
Superscript numbers <
not mentioned: ( X >
orrcspond to the list of references;
obsessive-compulsive symptoms;
'These patients were operated by Rxhardv>n; n.m..
ADHD, attention-deficit hypcractivity disorder.
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n.m.
14
15
2(1
19
24
23
19
28
17-22
19
45
40
33
34
40
n.m.
n.m.
21
29
28
21
31
34
19
40
11
15
20
23
21
23
26
19
m
f
n.m
m
m
f
m
n.m
n.m
m
f
m
f
m
f
m
m
m
f
m
m
m
m
m
rn
m
m
m
f
m
m
n.m
• • m
f
m
f
f
f
m
f
m
m
m
m
m
m
m
m
13
7
n.m.
29
n.m.
n.m.
10
n.m.
n.m.
n.m.
18
21
28
22
24
S
11
13
9
16
15
14
23
11
14
38
37
30
n.m.
37
n.m.
n.m.
12
16
14
13
23
12
14
33
7
3
9
17
15
19
18
13
tie» and C X ' J
t k s
n.m
tic» and I X J
tu-*
n n
HOS
uc>
tic>
tic»
no and IX'»
tic«
tic» and IX".»
n in
n in
tic»
no
n.m
n.m
tux and IH! t
n in
111 « 4lld ( H'»
In \ and (X'.«
tut and I K ' i
tut and CX'%
tic» and ()('.«
tin and C X \
tics Jiul O( \
ins ami C K'%
no and (X \
tic»
n. in
net
t u t
tic»
tics
tic»
tic»
t i n
t i l l
tic»
tic«
tic». A D H D and (X:»
tic«
tic»
tic». ADHD i m K X j
tin. ADHD and (X;*
tic»
Superscript numbers <
not mentioned: ( X >
orrcspond to the list of references;
obsessive-compulsive symptoms;
'These patients were operated by Rxhardv>n; n.m..
ADHD, attention-deficit hypcractivity disorder.
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Table 2 Target specification, outcome and complications in 65 paaents who underwent abbnve surgery tor intractable TS.
Refei Patient Surgical Surgical intervention
sessions
Follow-up Evaluation Result
(mos) method
Side effects
Baker'*
Cooper''
Stevens""
Hassler et al.'9. 22.
26
Nadvornik et al.20
Beckers et al.2'
Moldofsky ct al.21
Wassman et al.-**
Asam et al.^ 5
1
1
2 - *
1
1
2
3
4-9
10-13
1
1
2
3
]
1
1
1
3
n.m.
1
2
2
2
n.m
n.m.
1
2
2
1
2
n.m.
1
Cappabianca et al.-^ t
bimedial frontal leucotomy
bilateral thalamectomy (left repeated)
bilateral thalamectomy
prefronul lobotomy
coagulations in the intralaminar. medial and
Voi thalamic nuclei
coagulations in the intralaminar. medial and
Voi thalamic nuclei
coagulations in the intralaminar and medial
thalamic nuclei
coagulations in the intralaminar. medial and
Voi thalamic nuclei
coagulations in the intralaminar. medul and
Voi thalamic nuclei
bilateral dentatotomy
stercotactic surgery (target unclear) (2x)
bilateral campotomy and prerronta] leucotomy
bilateral leucotomy
bifrontal leucotomy, bilateral thalamotomy
prefronul lobotomy
unilateral stereotactic surgery (target unclear)
bilateral coagulation ZI
unilateral thalamotomy
unilateral thahunotomy
bilateral thalamotomy
12
22
n.m.
108
24
60
several
estimation "marked" reduction of des and OCs n.m*
n.m.
n.m.
n.m.
n.m.
n.m.
n.m.
n.m.
"rebet' ot tics
n.m
"marked decrease" of tics and
compulsions
1(K»% tic reduction
9ll% tic reduction
70% tic reduction
50-100% tic reduction
n.m.
n.m.
no side
effects
n.m.
n.m.
n.m.
n.m
years n.m.
n.m.
n.m.
"movements decreased, sounds
disappeared"
"slight improvement"
n.m.
n.m.
n.m.
n.m.
611
n.m.
n.m.
n.m.
n.m.
n.m.
"reduction of symptoms
n.m
"no long-term benefit"
n.m
"temporal" relief of tics
"temporal" relief of tics
"temporary improvement
"temporary improvement"
gait
problems
n.m.
n.m.
n.m.
n.m.
spastic
hemiplegia
spastic
quadnplegu,
dystom.1
contusion
n.m.
"slight reduction" of compulsions n.m.
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Table 2 Continued.
Reference Patient Surgical Surgical intervention
sessions
Follow-up Evaluation Result
(men) method
Side effects
6
7
8
9
10
n.m
1
n.m
n.m
n.m
11 n.
12 1
13 1
14 1
15 1
U> 1
unilateral coagulation of ZI and unilateral
thalamotomy
unilateral thalamotomy
bilateral coagulation of Z l
bilateral coagulation of Z I
bilateral coagulation of Z l
bilateral coagulation of Z I
bilateral coagulation of Z I and bilateral
thalamotomy
bilateral coagulation of Z I and bilateral
thalamotomy
unilateral coagulation of Z l and unilateral
thalamotomy
unilateral coagulation of Z l and unilateral
thalamotomy
unilateral coagulation of Z I and unilateral
thalamotomy
13 tic scoring 52% be reduction
n.m oc scoring 52% DC reduction
n.m tic scoring 45% Qc reduction
7 tic scoring 45% DC reduction
H.5 tic scoring 45% be reduction
9.5 oc scoring 45% be reduction
5.5 DC scoring 45% be reduction
3.5 be scoring 45% be reduction
7 be scoring 52% be reduction
4.5 tie scoring 52% be reducbon
4.5 tic scoring 52% be reducbon
dysanhria,
hemiparais
n.m.
dyMonu
dystoma.
dyurthru
dystonu.
dysarthna,
CS
n.m.
dysarthria,
hemiballism,
CS
heniipareM*.
CS
CS
dystonia, CS
Surgery in Toureof Syndrome 73
In the same year. Cooper'' published the case of a 16-year-old girl. This patient
had a 7-year history of vocal and motor tics and had received various therapies
including drugs, hypnosis, and psychoanalysis, without success. A right
chemothalamectomy was carried out. followed by a left chemothalanuvtomy 1
year later. Cooper reported that after the surgery, the patient had a substantial tic
reduction and was functioning fully.
Two years later, Stevens"' published the long-term follow-up result of a 37-year
old man who had undergone the first prefrontal lobotomy. earned out by James
Watts in 1955. At the of age 8, the patient presented with severe motor and vocal
tics and OCs. Psychotherapy and pharmacotherapy had no effect on the symp-
toms. After the operation, there was a marked decrease m the frequency, duration
and amplitude of the tics. No specific complications occurred. Stevens concluded
that lobotomy, "although an extreme measure", seemed justified in the treatment
of intractable TS. As in the report from Cooper, no information is provided
regarding the method of tic rating.
Seven years after his first report. Cooper summarized his experience in the treat-
ment of "multiple tics" by bilateral thalamic surgery in 6 patients in Ins textbook
/Mi'o/MHftiry A/oi-mifM Diiwdra'^. He described TS as "a syndrome sharing many
features of dystonia". The first patient who underwent bilateral surgery was
described in detail. This was the same patient previously described in 1962'\ In
this report, however, more details were provided with regard to the target
(ventrolateral nucleus of the thalamus) and follow-up. In I'>(>(>, the left
thalamotomy was repeated in this patient because of persistent symptoms on the
right side. This had no effect. Cooper described this patient as an illustrative case,
without providing details of the other 5 cases.
Four years later Sweet et al"* reported briefly on the long-term follow-up of one
of the patients in Cooper's series. This was a 26-year -old woman who was oper-
ated on in 1963, with partial relief of symptoms.
In 1970, Hassler and Dieckmann''^ reported on the results of bilateral thala-
motomies in 3 patients with intractable TS. They carried out more than 10 coag-
ulations in the intralaminar and medial thalamic nuclei, and, in case of facial tics, in
the nucleus ventrooralis internus (Voi). Only the effects with respect to tics were
reported, which improved by 1(H)% in Patient 1, 9()% in Patient 2, and 7()% in
Patient 3. Again, no details about the tic-rating method were provided.
1971-1980
In the next decade, the first report on the surgical treatment of TS was by
Nadvornik et aP" describing a case of stereotactic dentatotomy. The patient was a
12- year -old boy suffering from vocal and motor tics. The motor tics were mainly
in the facial and abdominal region. Bilateral dentatotomy was performed
transtentorially. The authors reported "a decrease of movements", but did not
specify whether they meant motor tics or normal motor function, and "a disap-
pearance of vocal tics". They concluded that bilateral dentatotomy could be an
effective treatment for intractable TS. No specification of the tic evaluation was
given.
One year later, Beckers**' published the outcome of the neurosurgical treatment
in 3 TS patients. The patients were 26, 31, and 35 years old with disease onset at
the age of 5, 10, and 7 years, respectively. All patients suffered from vocal and
motor tics and OC.s. Neither psycho- nor phannacotherapy had any long-term
beneficial effects. Two stereotactic operations (target unclear) were carried out in
Patient 1 (female) with an interval of 1 year between surgeries. Patient 2 (male)
underwent a bilateral campotomy and prefrontal leucotomy in two surgical ses-
•* sions. A bilateral leucotomy was performed in the third patient (female). The
S author observed that these stereotactic interventions resulted in partial tic reduc-
-3 tion. Nevertheless, surgery was not advocated as a good treatment option for
intractable TS because of the side effects, which were not specified. Beckers^' did
not describe the way tic reduction was assessed.
In the same year. Hassler and Dieckman-^ wrote a chapter of the textbook SMrtjiVa/
i!/7>r<>i<7i<\< /»/ /»)'<7ii'<»r)'-- in which they described their experience in the surgical
treatment of OCI), phobias, and tics. In 9 patients suffering from TS, the results
after stereotactic coagulation of intralaminar and medial thalamic nuclei were
summarized. Unfortunately, they only described the outcome of the surgical
intervention without providing detailed information about the patients. Three
patients underwent unilateral, and six patients bilateral procedures. The authors
reported that 1 patient who had undergone unilateral surgery and three patients
with bilateral surgery had a 90 to 100% improvement in tics. Two unilaterally and
3 bilaterally operated patients experienced a 50 to 80% tic reduction. No mention
was made of duration of follow-up, methods of tic rating or side effects. One year
later, Moldofsky et al~-' reported on 2 patients who had undergone surgery for
intractable TS. The first case was the one operated by Baker''' as described earlier.
In contrast to this first author. Moldofsky et al concluded that no long-term bene-
ficial effects were achieved. The second patient was a 27-year-old man with vocal
and motor tics, the first symptoms appearing at the age of 5 years. The patient
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underwent bilateral Frontal leucotomy and later, for unclear reasons, bifrontal
thalamotomy. Details ot the results and side effects, were not reported.
In 1978, Wassmann et al-* briefly mentioned a female patient who had under-
gone a prefrontal lobotomy without giving any information about the outcome.
1981-1990
Asam et al-* provided a brief (and incomplete) review of the literature on surgical
interventions in TS and reported their experience with two TS patients. The
patients were both men, 14 and 15 years old, with disease duration of 5 and 11
years, respectively. Their first patient underwent stereotactic surgery (target
unclear) with temporary relief of tics. Postopcratively. this patient developed a
spastic henuplegia. Coagulation in the left zona incerta (Zl) was carried out in the
second patient, who also had a postoperative hemiplegia. The same patient was
operated on 15 months later, for unclear reasons, in the contralateral / I . I'ostop-
eratively. this patient developed hemiplegia on the left side and became quadri-
plegic. According to the authors, temporary relief of symptoms was achieved in
this patient. Later, tics reoccurred in combination with complex dystonic move-
ments. They concluded that surgical intervention in IS may produce temporary
improvement of tics and that surgery can be accompanied by severe side etlects.
In 1982, Hassler"' updated the material on stereotaxic surgery for psychiatric dis-
turbances in Schaltenbrand's textbook and briefly mentioned his experience
with thalamic surgery in 15 patients suffering from intractable IS. No details
were provided about the outcome.
In 1987, Cappabianca et aP' published the long-term results of 3 patients
desenbed initially by de 1 )ivitiis et al-*, and of one new patient. In addition, they
provided a review of (all) operated patients. This review was incomplete since the
patients described by Nadvornik et al-". Cooper"'- " , and most of those described
by Hassler--' -'', were not included. Their operation was based on stereotactic
coordinates proposed by Hassler and Dieckmann'''. The intralaminar and
dorsomedian nuclei of the thalamus were coagulated bilaterally in I patient and
unilaterally in 3. The authors reported temporary tic improvement in 2 patients
lasting a few months, a slight reduction of compulsive symptoms in 1 patient, and
an almost complete tic regression in the fourth. The follow-up of these patients
was several years shorter than one would expect when considering the publica-
tion year.
Robertson et al -'' reported on a 19-year- old man with disease onset at the age of
5.5 years, presenting with a variety of verbal and motor tics. The verbal tics
included coprolalia: the motor tics involved mainly the head, neck and facial
region. Behavioral disturbances, mainly checking, and severe self-injurious
behavior, were also present. The tics were treated successfully with the D2 recep-
tor antagonist, sulpiride: the compulsions however, could not be treated.
Stereotactic limbic leucotomy was performed involving bilateral lesions in the
lower medial quadrants of the frontal lobes and separate lesions in the anterior
cingulum (limbic leucotomy). Fostoperatively, the compulsions disappeared
within 6 weeks. Side effects consisted of apathy, general intellectual impairment,
organizational problems, and difficulties in concentration. After 2 years, the
patient was socially independent and free from self-injurious behavior. Accord-
ing to the authors, there was a tic-reduction of 75%. This is an interesting remark
since the authors reported a "complete resolution" of the tics by medication preop-
eratively. I'ostoperatively, the patient continued on drug-therapy with an increased
daily dosage. Robertson et al concluded that limbic leucotomy should be consid-
ered an effective treatment in TS patients with severe self-injurious behavior, but
emphasized that the long-term effects on tics required further assessment. Again,
the method of tic evaluation was not mentioned, nor was the impact or the time
course of the side effects, nor the criteria for the diagnosis of TS.
J Kurl.ui et al •"'• •" described their neurosurgical therapy in 2 patients with TS andcomplex (X'l). The first patient was a 28-year-old man with disease onset at the
age of 5 yean, suffering from OCs. The patient had attempted suicide and subse-
quently was treated successfully with medication for a bipolar affective disorder.
The patient was severely disabled by the tics and OCs, without any effect of phar-
macological therapy. A bilateral cingulotomy was performed. The authors
reported an improvement of 25 to 30% in ritualistic behavior without any effect
on tics, at long-term follow-up (2 years). No side effects were mentioned. The
second patient was a 22-year-old man who had undergone bilateral cingulotomy
at age 17. Symptoms were reduced for approximately 10 days and later returned
to the preoperative state. One year postoperatively, the procedure was repeated
and the patient showed a lasting improvement. Kurlan et al proposed that
cingulotomy should be considered a valuable treatment option for patients with
TS complicated by resistant OC1). The improvements were assessed by the
authors without the use of clinical rating scales. The side effects were not men-
tioned.
1991-2000
In 1993, Sawle et aP- reported on the results of bilateral limbic leucotomy in a
45-year -old man suffering from TS. The symptoms consisted of severe self-inju-
rious behavior, obsessions and compulsions, and vocal and motor tics. Long-term
trials of pharmacological and behavioral therapy had failed. During limbic
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Figure I. Brain areas thjt luve been targeted in surgery for TV and other relevant neuroaiutoimcal vtrui-
turev The frontal lobe (3) was targeted during prefrontal lobotomy and himrdul Inn oioiny In limbic
leucotomy and antenor cingulotomy. the cingulate cortex (I) »11 Iruuned. I he thalamm (7) wj\ targeted lor
loioning of the midline. intralannnar and venlrolateral thalanm nuclei and for DUN ItilullulaMiu IrMon«
were earned out at the level of the H field» of l-orel (II) and the roru nuerta (S) I erebellar «irnrr\ involved
Intoning of the dentate nut lern (16) The turrounding brim arrai iiulude (2) ixrpu« lalUmnn, (4)
caudatr-puumen complex. (6) globu« palhduv (8) «ubthalamic nucleu«. (9) \uhMamia ni|(ra. (10) |»»(rnor
commissure. (12) supenor colhculus, (13) inferior colluulm. (15) superior cerebellar peduncle, and (14) optic
chiasm.
leucotomy, bilateral coagulations were carried out in the anterior hypothalainus
and cingulate gyrus. However, in a personal communication to Kauch et aP\
Sawle remarked that the actual targets "were those of conventional limbic
leucotomy (cingulotomy plus thennocoagulation of the frontothalamic fibers).
According to the authors, the surgery had no direct effect on tics whereas the
compulsions were reduced. Nineteen months after surgery, however, there were
no longer any signs of tics and the patient reported excellent improvement with
regard to his obsessions.
A 40-year-old man suffering from TS and OCI) who underwent surgery was
reported by Leckman et aP"* in 1993. The disease onset was at the age of 3 years
with motor tics. Vocal tics later appeared and checking and cleaning compulsions
were present, as was self-injunous behavior. Symptoms failed to respond to medi-
cation trials. The patient underwent bilateral stereotactic infrathalamic lesion»
and anterior cingulotonues. Fostoperatively, the obsessive-compulsive symp-
toms had improved, but the patient continued to experience severe motor and
vocal tics. Three weeks later, the left infrathalamic and cingulated lesions were
repeated. During this second surgical session, the infrathalamic lesion was
extended more inferiorly within the borders of the red nucleus and a subsequent
coagulation was performed in the H fields of Forel. The patient had severe neuro-
logical deficits postoperatively including dysarthria, dysphagia, handwriting and
gait problems, mild hemiparesis, abnormal extraocular movements, axial rigidity,
and bradykinesia. The authors suggested that these side effects were due to exten-
sion of the infrathalamic lesion. At long term there was a reemergence of tics and
()(II). The authors concluded that lesioning brain areas does not only influence
pathological, but also destroys physiological functioning.
One year later, Baer et al •"• reported on the effect of cingulotomy in a patient with
TS and OCD. The patient was a 35-year-old man with OCD and associated TS
since the age of 5 years. He failed to respond to either behavioral therapy or medi-
cation. The patient underwent two sessions of cingulotomy with an interval of 18
months between procedures. After the first and second operation, there was no
clear effect on his tics. However, this procedure resulted in an improvement of
the OCs. The authors concluded that cingulotomy alone was not an effective
<«• treatment for TS.
g In 1995, Ranch and co-workers'-' published a comprehensive review of the
neurosurgical treatment of TS. They provided detailed information about the
different neurosurgical approaches by summarizing the available literature. In
their report, emphasis was placed on the rationale for the different targets. In total,
36 cases were reviewed. Their review was incomplete as the reports by Beckers et
aP', Sweet et al"*, Moldofsky et al-\ Wassman ef dp"*, and Asam cf d/^ were not
included. Mention was made, however, of a personal communication from
Kichardson regarding 3 patients who had undergone a bilateral anterior
cingulotomy and infrathalamic lesioning, which had not been published before.
The first patient was a 34-year-old woman with severe TS, OCD and bipolar dis-
orders. The patient underwent an anterior cingulotomy plus infrathalamic
lesions. Tic-counting on videotapes performed by Rauch et al, revealed a
decrease from 18 tics/minute to 2 tics/minute. The second patient was a
40-year-old man suffering from self-injurious motor tics, coprolalia, and OCD.
The third patient was not described in detail. The latter 2 patients underwent the
same procedure as the first, with poor outcome. Furthermore, the second patient
had dysarthria and swallowing, handwriting and gait problems postoperatively.
There was only a moderate improvement of tics and OCD. The third patient
showed no improvement in symptoms at all. In addition, Rauch et al mentioned a
case published in the Russian literature by Korzen in 1991. This involved a
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19-year-old man with TS and associated OCD who had undergone bilateral
cryothalamotomy (ventrolateral nuclei) with good results at 1 -year tollow-up.
Several years later, Korzenev and colleagues^ published results of their surgical
treatment of 4 intractable TS patients. They concluded that stereotactic surgery
was an erlective method ot treatment tor severe incurable TS. However, in their
paper no description of the TS patients was provided with respect to patient char-
acteristics, tics, surgical target, or method of evaluation.
2()01 -Present
Babel and co-workers^ reported on results with surgical therapy in 16 intractable
TS patients, diagnosed according to the Tourette Syndrome (Classification Study
Ciroup™ (TSCSCi) criteria, that were operated on between 1970 and I9'>8.
Long-term evaluations were obtained from 11 patients. Tic severity was evalu-
ated using a tic severity rating scale. All patients suffered from vocal and motor
tics. ADHD and OCD were documented in 3 patients. Seven patients were
operated unilaterally and 9 bilaterally. Eleven patients underwent coagulations in
both the ZI and thalamus, 4 were operated at the level of the Zl. and I patient
underwent unilateral thalamotomy. There was a significant reduction in vocal
and motor tics immediately postoperatively and at long -term. Almost all patients
remained on multidrug therapy. Several patients experienced complications as a
result of the intervention, varying from mild hemiparesis to hemiballism. The
authors concluded that unilateral ZI and VL/LM (ventrolateral/ lamella medialis
of the thalamus) lesioning in patients with asymmetrical symptoms resulted in tic
reduction, but that larger prospective random trials were needed to validate the
role of surgery in TS. They did not, however, provide any background informa-
tion as to why the Zl and thalamus were targeted.
DEEP BRAIN STIMULATION
In total, 3 patients undergoing DBS for TS have been reported. The first report
was in 1999 by Vandewalle et aP'\ At the X Vth European Society for Stereotactic
and Functional Neurosurgery, the long-term effects of this therapy were pre-
sented^". The patients were male and were 42, 2S and 45 years old. They were
selected based on intractable TS with absent comorbidity (except for associated
behavioral problems), a diagnosis made according to the criteria of the TSCSCI.
Other than vocal and motor tics, the patients had compulsive behavior (see Table
3). Psychotherapy had failed in all cases and various drugs were found to have no
effect or had to be stopped after prolonged use because of unbearable side effects.
The target was at the level of thalamic nuclei as selected by Hassler and
e/ectrode
Figure 2. During DBS, stereotactic coordi-
u l n were chosen to place (he electrodes in
this area. Hassler and Dieckmann carried out
at least 10 thalamic coagulations on each side.
For DBS. a strategic point had to be chosen
where the different thalamic nuclei could be
influenced through one electrode. According
to the target coordinates, the three groups of
nuclei that were lesioned by Hassler and
Dieckmann are affected through stimulation
of the centromedian nucleus (Ce; as part of
the intralaminar thalamic nuclei), the sub-
suntu penventnculans (Spv; as part of the
nudline thalamic nuclei), and the Voi.
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Dieckmann'''. I )HS was chosen because of its safety, reversibility, and adjustabil-
ity. I lassler and 1 )ieckmann had successfully performed lesions in the midline and
intralaminar thalamic nuclei as a treatment for TS, as described previously . In
some patients with facial tics, they additionally carried out lesions of the Voi.
Whereas Hassler and I Dieckmann performed at least 1 (> coagulations on each side,
in this case a strategic point had to be chosen where the different thalamic nuclei
could be influenced through one electrode. According to the target coordinates,
the three groups of nuclei that were lesioned by Hassler and Dieckmann are
affected through stimulation of the centromedian nucleus (as part of the
intralaminar thalamic nuclei), the substantia periventricularis (as part of the
midline thalamic nuclei), and the Voi (see figure 2). Each patient was videotaped
with both stimulators o;i and 12 hours <>/£ Two independent and blinded investi-
gators counted the number of tics. At long-term follow-up (5 years for Patient 1,1
year for Patient 2, and 8 months for Patient 3), there was a tic-reduction of 90.1 %
in Patient 1, 72.2% in Patient 2 and 82.6% in Patient 3"". Neuropsychological
evaluations showed no effects of surgery. Patients 1 and 3. however, reported
changes in sexual drive. Laboratory evaluations in stimulation ini and o/f condi-
tions demonstrated that penile erection in response to visual erotic stimuli was
increased in Patient 1 and inhibited in Patient 3 during stimulation. Furthermore,
all patients described a feeling of "reduced energy" at the stimulus intensity neces-
sarv for the best effect on tics.
Table 3 Patient characteristics and the outcome of deep brain stimulation in three Tourene Syndrome paoents who did not repond to various nub of pharmacological and
behavioral therapy
Reference
Vivser-
Vandewillc
et al.->l
Patients
1
1
1
Age at
surgery
(yr)
42
28
43
Gender Disease
duration
(yr)
m 37
m 20
in 38
Tics
vocal and
motor
vocal and
motor
vocal and
motor
Associated
behavioral
symptoms
Compulsions
Automutilation,
compulsions
compulsions
Indication
for surgery
Do and OCs
ocs and OCs
ocs and OC*
Surgical
senior»
1
1
1
Surgical
intervention
DBS of
thalamus
DBS of
thalamus
DBS of
thalamus
Follow-up
(mos)
tt)
12
tt
Evaluation
method
bunded tic
scoring
Minded tic
scoring
Minded tic
scoring
Result at
long term
<*).!% tic
reduction
72.2% oc-
reduction
H2 6% oc-
reducUon
Side effects
increased
sexual drive,
"reduced
energy
reduced
concentration
reduced
sexual drive,
"reduced
energy"
DISCUSSION
Many different lesioning procedures have been performed in TS throughout the
history of surgical treatment of this disorder. Frontal lobe operations included
prefrontal lobotomies and bimedial frontal leucotomies. The limbic system was
targeted during limbic leucotomy and anterior cingulotomy. Thalamic opera-
tions included lesioning of the medial, intralaminar and ventrolateral thalamic
nuclei Infrathalamic lesions were performed at the level of Forel's fields
(campotomies) and the zona incerta. Cerebellar surgery included dentatotomies.
In an attempt to achieve total control of symptoms, more complex operations
have been carried out, such as combined anterior cingulotomies and infra-
thal.imic lesions.
The question arises of how the authors could be certain of their target localiza-
tion. Most reports do not mention impedance measurements, depth recordings
or postoperative imaging. In some reports, the target is not even mentioned and
the only thing we know is that "stereotactic surgery " has been performed^' • ^ - •*'•.
* Another criticism is the lack of criteria according to which the diagnosis ofTS was
S. made. ()nly Mabel et al" mentioned that the diagnosis being made was according
Q to the criteria of the TSCSCI. So it may well be that several patients in the other
~ reports were not suffering from typical TS but from TS with prominent and prob-
ably more disabling comorbidities, or other tic disorders. Furthermore, most
reports lack any specification of tic reduction, let alone the tic evaluation methods
adopted. Only Hassler'^ " , Robertson et al-'\ Kurlan et aP", Leckman et aP"»,
Rauch et aP' and Mabel et al" described the outcome in percentages and only
Robertson et al-'\ I .eckman et aP"*, Rauch et al-" and Mabel et al-" specified the tic
evaluation method. The results of these latter reports also have to be interpreted
with caution since they lack blinding and independance of the assessors. More-
over, in the postoperative phase many of the patients still used, or were again
placed on drug-therapy. All these confounding factors could influence the results.
Hence, for many reasons these reports cannot be considered as a body ot informa-
tion on which one can base conclusions about the optimal surgical treatment in
intractable TS.
The lack of rationale for choosing specific targets for these ablative procedures is
striking and makes most of them hazardous from an ethical point of view, espe-
cially when the complications are taken into consideration. These vary from
dystonia to even qu.idriplegia. A possible reason for this lack of rationale might be
the uncertainty about the pathophysiology ofTS in the past. Through advances in
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genetics, pharmacology, and brain imaging, one now has access to more data on
the possible mechanisms underlying TS.
It is also remarkable that very young patients have been included in those selected
for surgery. For example, one of the patients described by Dabei et aP~ was only 11
years old. Nadvornik et al-'" operated on a 12-year-old boy. It is well known now-
adays that TS can be a self-limiting disease with symptoms disappearing in early
adulthood.
In 1999, the first DBS was carried out for intractable TS, with the target for
thalamic stimulation based on the thalamotomies described by Massier'**' '-• -'V
Since then, 3 patients have undergone a bilateral thalamic stimulation with good
results. The thalamus seems to be a promising target. The involvement of the
thalamus in the pathophysiology of TS is dual in nature: whereas the medial and
ventral thalamic nuclei are way stations within the basal ganglia-thalamocortical
circuits, the midline and intralaminar nuclei send projections to boih the
premotor/prefrontal cortex and the striatum. Therefore, the basal gan-
gha-thalamocortical pathways are influenced strongly, at the level of their major
input (the striatum). by excitatory thalamic input.
We conclude that surgery in TS must continue to be considered experimental. If
one takes into account the actual knowledge that high-frequency stimulation
generally has the same clinical effects as lesioning, apart from its reversibility, car-
rying out ablative procedures for TS can no longer be justified. It is clear that a
study on more patients is required with a strict protocol, including well-defined
inclusion, and exclusion criteria, well-defined targets for surgery, and clear speci-
fications of evaluation methods for tics and other symptoms. A single evaluation
of the effect of surgery is most probably not sufficient due to natural fluctuations
in symptom severity and their modulation by psychosocial factors. In addition,
systematic inquiry into potential adverse effects and careful documentation of the
presence and severity of associated behavioral disorders must also be included.
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CHAPTER 5
Chronic bilateral thalamic stimulation:
a new therapeutic approach in intractable
Tourette syndrome
A report of three cases
Veerle Visser-Vandewalle, Yasin Temel, Peter Boon. Fred Vreeling,
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Abstract
Based on the results of thalamotomies described by Hassler in 1970, the authors
performed bilateral thalamic high frequency stimulation (HFS) in three patients
with intr.nt.iblc Tourcttc syndrome (TS). In this report they describe the
long-term eflcctv
Three nulc patients (42. 2H, and 45 yean of age) had manifested motor and vocal
tic« since early childhood. The diagnosis of Tourette syndrome was nude accord-
y, ing to the criteria of the Tourette Syndrome Classification Study Group
i (TSCS(i). Any drug or alternative treatment lud been either ineffective or onlytemporarily effective in all three patients. There was no serious comorbidity.The urge! lor stimul.ition was chosen .it the level of the centromedian nucleus,
88 stilist.mtu piTiVTiitrii.iil.iris and nucleus ventroorahs internus. After 2 weeks of
test stimulation, the pulse generators were implanted.
After a follow-up period of 5 years in the patient in Case 1, 1 year in the patient in
Case 2, and S months in the patient m Case 5, all major motor and vocal tics had
disappeared and no serious complications had occurred. When stimulation was
applied .it the voltage necessary to achieve an optimal result on the tics, a slight
sedative effect w.is noted in all three patients. In the patients in Cases 1 and 3 there
were stimulation-induced changes in sexual behavior.
Chronic thalamic HFS may be an effective and safe treatment for medically intracta-
ble TS in .ulult patients. Unwanted stimulation-induced side effects may occur.
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Tourette syndrome is a chronic neurological disorder with an onset in early child-
hood that is characterized by tics. These tics are defined as sudden, brief, intermit-
tent, involuntary or semivoluntary movements (motor tics) or sounds (phonic or
vocal tics).
They may be abrupt in onset, fast and brief (clonic) or slow and sustained
(dystonic or tonic) '"*. Once considered to be a rare and bizarre syndrome, TS is
now recognized as a relatively common, biological, genetic disorder with .1 spec-
trum of neurobehavioral manifestations that characteristically wax and wane dur-
ing its natural course. In addition to motor and vocal tics, patients with TS often
have a variety of behavioral symptoms, particularly those associated with atten-
tion deficit-hyperactivity disorder and obsessive-compulsive disorder "• '**• •*•'.
Drug treatment of TS consists of neuroleptics and other agents interacting with
the dopaminergic system''*. Side effects such as depression, drowsiness, weight
gain and extrapyramidal symptoms are a major drawback for their prolonged use.
Frequently, TS is found to be a self-limiting disorder as the patient reaches adult-
hood, whereas in a small proportion of the patients the tics continue into adult life
and require long-term medication. Behavioral therapy has not been proven to be
effective at long term.
Surgery has rarely been performed in TS. Hassler and Dieckmann"' "• '"carried
out bilateral coagulations of the midline and intralaminar thalamic nuclei and the
inner part of the ventral oral thalamic nuclei in three TS patients, resulting 111 par-
tial relief of tics. In 1997, we performed stereotactic bilateral HFS of the tli.il.imic
nuclei targeted by Hassler in a patient with intractable TS'". In the present study,
we report on the long-term effects of bilateral HFS of the thalamus in three
patients with TS. We chose HFS because of its safety and reversibility. We
obtained permission from the hospital's ethics committee, and all patients gave
their informed consent.
CLINICAL MATERIAL AND METHODS
Patient characteristics
Three patients were selected on the basis of intractable TS with absent coinorbid-
ity. The diagnosis was made according to the criteria of the TSCSCJ*' Character-
istics ot tics with their frequencies per patient and per tic are shown in Table 1.
The impact of the tics as determined by each patient is presented in Table 2. All
three patients suffered from compulsive behavior. None of the patients or their
partners reported obsessions (such as sexual obsessions). Psychotherapy had failed
in all patients and medication, including various dopamine-depleting or dopa-
mine receptor blocking agents and clonidine, either had no effect or had to be
withdrawn after prolonged use because of unbearable side effects, depression
being the most important.
In all patients blood chemistry, electroencephalography and MR-images were
normal. Neuropsychological evaluations were performed in the patients in Cases
1 and 3.
Evaluation of tics
One week postoperatively the patients were evaluated by a blinded examiner
while the neurosurgeon manipulated the pulse generator. In all patients an assess-
ment of the acute effects ofbipolar (poles () and 1 negative, 2 and 3 positive) stimu-
lation with a frequency of 125 Hz and a pulse width of 210 usec was performed.
Randomly, the amplitudes of both installed stimulators were set between 0 V and
the maximum voltage, which was defined as the voltage above which the patient
felt an unpleasant sensation of dizziness (Case 1:6V bilaterally; Case 2: 4.5V for
the left and 4 V for the right; and Case 3: 5V for the left and 3V for the right). Each
evaluation was performed 15 minutes after manipulation of the stimulus inten-
sity. Each session contained two periods during which both stimulators were
switched off, and installed at the maximum voltage.
At the long-term follow-up (5 years for Case 1,1 year for Case 2, and 8 months for
Case 3), each patient was recorded on videotape for 20 minutes while chronic
bilateral stimulation was applied, and for 20 minutes after both stimulators had
been switched off for 12 hours. The number of tics displayed on the videotapes
was counted by two independent, blinded investigators (Y.T. and G.H.) during a
period of 10 consecutive minutes, which showed the greatest variety of tics on the
videotape. For tonic tics, the duration was counted in seconds.
The number of tics and compulsions are described in Table 1. Table 2 presents the
impact of the symptoms on self-esteem, familial and socio-professional life, as is
estimated by the patient.
Surgerical procedure
The target was defined 5 mm lateral to the AC-PC line, 4 mm posterior to the
midcommissural point, and at the AC-PC plane. Test stimulation was performed
using a rigid monopolar electrode with a 2- nun naked tip (model 3101-2;
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Figure 1. Ci\c I l'o\io|>ci.iiivr MR iiiu^r (tomiury \litlc)
obtained in j pjtient jltcr implantation ol two clritrodei
demonstrating their position in the medial part of I lie
th.il.unuv
Radionics, Burlington, MA). After a test stimulation (frequency 100 Hz, pulse
width 200 u.sec) during which special attention was paid to unwanted effects
(except in the patient in Case 2 in whom general anesthesia was induced), the test
electrode was replaced with the final, quadripolar electrode (model 33H7;
Medtronic, Kerkrade, The Netherlands), which was fixed in the burr hole with
acrylic cement. In all patients fluoroscopy was used to evaluate the position of the
quadripolar electrode before its fixation.
After the stereotactic operation, there was a test period of approximately 2 weeks
in all patients when externalized electrodes were used. I )uring this time, a postop-
erative MR-image was obtained (Fig. 1). In all three patients, this MR-image
demonstrated a good position of the electrodes, with no abnormalities.
In the patients in Cases 1 and 2, two Itrel III pulse generators (model 7425,
Medtronic) and in the patient in Case 3, a Kinetra pulse generator (model 7428;
Medtronic) was implanted infraclavicularly at a second stage.
Illustrative cases
C<J5f /. This man was 42 years of age at the time of surgery, which was performed
by V. V. V. The first tics had appeared at the age of 5 years and had consisted mainly
of eye blinking and grimaces. As a child, he used to hurt himself by cutting his
arms with a knife. From the age of 17 years, the most frequent tics consisted of
licking objects, including his own shoulders, and making turning movements
with his neck. Vocal tics consisted of throat clearing, uttering meaningless sounds,
and blowing. Frequently he could not sit still on a chair and made adduction
movements of the knees. He suffered from checking compulsions, such as
inspecting doors and lights. The patient and his partner confirmed that the tics had
a greater impact on their lives than the compulsive behavior.
During surgery, the stereotactic frame (Leksell G frame; Elekta, Linköping, Swe-
^, den) was fixed while the patient was sedated with propofol delivered through a
i l.irynge.il m.isk. After defining the target on the CT-scan by using the aforemen-tioned coordinates (5 mm Literal to the AC-I'C line, 4 mm posterior to the middleof the AC-PC line, and at the AC-PC plane), sedation was tapered and the laryn-
•2 geal mask was removed. At that time, the patient did not display any tics and was
sufficiently cooperative for test stimulation to be performed. We started at his left
side because we thought that the dominant hemisphere might have a greater
impact on the tics than the nondominant one.
A burr hole was made and the test stimulation initiated. At target minus 6, and tar-
get minus 4, there was no effect following the application of 3 V. At target minus
2, the patient reported a pleasant feeling at 1.75 V. At target, this pleasant feeling
was very intense, and the patient compared it with a feeling of euphoria elicited by
drugs and felt that it would have a positive effect on his tics. At target plus 2, this
pleasant feeling returned, at 2.25 V, albeit less intense. The test electrode was
replaced by the final quadripolar electrode with pole 1 (the second deepest pole)
installed at the target.
On liis right side we started stimulation at the same point. During stimulation of
the target, however, the patient reported an intense sensation of fear and begged
us to stop. The test stimulation electrode was reinstalled at a location 2 mm more
medially, and here, at target, the patient again experienced a pleasant feeling of
euphoria. The quadripolar electrode was installed at this site, with pole 1 at target.
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On the 1st postoperative day, the patient progressively raised the voltages on the
right and left sides, to intensity- the pleasant feeling. He increased them very sud-
denly to 6 V bilaterally, after which he experienced a sudden intense rebound of
tics accompanied by dizziness. We set the voltages at 2 V bilaterally and instructed
the patient not to raise stimulation to more than 3.5 V, after which there was an
important reduction of tics.
C«t$f 2. This man was 28 years of age at the time of surgery, which was performed
by H.C. His first tics had appeared as grimaces at the age of 8 years. At the time of
surgery, the patient's most disabling tics consisted of screaming, head shaking and
obscene finger gestures. He performed automutilation by burning his eyelashes
with cigarettes. Because of his tics and the compulsion to touch people, he
became completely socially isolated and lived with his parents.
The patient was placed under general anaesthesia throughout the stereotactic
procedure, for which the Cosman Roberts Wells frame (Radionics) was used.
The target was calculated on fused CT and MR images. The quadripolar elec-
trodes on both sides were installed 5 mm lateral to AC-I'C, 4 mm posterior to the
middle of the AC-PC line, and at the AC-I'C plane, with pole I at target.
Postoperatively, during test stimulation performed by external screeners, the
need to touch people and to self-mutilate had completely disappeared.
Case 3. This man was 45 years old at the time of surgery, which was performed by
V. V. V. He had suffered from tics from the age of7 years. The first tics consisted of
grimaces and tongue pulling. As an adult, the most disabling tics included pound-
ing the stomach and screaming. Flexion movements of the head and touching the
head also had a great impact on the patient's social life. Apart from screaming,
vocal tics consisted of throat clearing, coughing and sniffing. The patient's hands
were frequently wounded because whenever he saw a glass, he was compelled to
break it.
During the stereotactic procedure (for which the Cosman Roberts Wells frame
was used), the patient was sedated with clonidine and lorazepam. The target coor-
dinates were calculated on fused CT and MR-images.
We started test stimulation on the right side. From target minus 6 until target, no
effect was noticed by the patient or the examiner, up to 3 V. We installed the
quadripolar electrode with pole 1 at target. On his left side, the patient showed an
eye deviation at target plus 4, suggesting that the electrode was located in the
mesencephalon. We made a second trajectory 2 mm more medially. Here, there
was no effect at target minus 6 until target plus 4 up to 5 V, and the quadriploar
electrode was installed with pole 1 at target.
Postoperatively, the screaming, stomach pounding, and compulsions to break
glass had completely disappeared at 2.5 V. The patient experienced a slight feeling
of dizziness at the voltage necessary to reduce his tics, which he compared to the
effects of one glass of wine.
RESULTS
Effect on tics
One week postoperatively there was a tic reduction of 82.5% in the patient in
Case 1 (from 422 tics/10 minutes to 74 tics /10 minutes), 60.5% in the patient in
Case 2 (from 205 tics/10 minutes to HI tics /10 minutes), and of 53.6% in the
patient in Case 3 (from 196 tics/10 minutes to 91 tics/10 minutes). In all patients
the most disabling tics were absent.
in
j[_ At the long-term follow-up, there was a tic reduction of 90.1% in Case 1 (from
g 422 tics/10 minutes preoperatively to 42 tics / 10 minutes at 5 years), 72.2% in
Case 2 (from 205 tics /10 minutes to 57 tics/ 10 minutes at 1 year), and 82.6% in
Case 3 (from 196 tics / 10 minutes preoperatively to 34 tics /10 minutes at 8
months). The results per patient and per tic at the long-term follow-up are pre-
sented in Table 1.
The patient in Case 1 still demonstrated minor turning movements of the head,
blowing, uttering sounds and leg movements. These tics were clearly reduced in
quantity and in intensity.
In the patient in Case 2. the smallest effect was seen on the grimaces. Although
preoperatively his entire face had been involved, including the mouth opening
widely, postoperatively these grimaces were restricted to the forehead and eye
musculature. In the patient in Case 3 a few tendencies to scream were noted dur-
ing the 20- minute videotape as well as minor flexions of the head and blinking of
the eye. In all patients the remaining symptoms had a minimal impact on
self-esteem and familial and socioprofessional lives; however.the remaining gri-
maces in the patient in Case 2 led to moderate problems (Table 2).
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Cat« 1
Motor no
Licking of objects/shoulders
Turning movements of head
Eyr blinking
Adduction of knee*
I'oco/ no
Throat clearing
Uttering rounds
Blowing
TOTAL
C * M 2
Motor no
Head shaking
Obvene finger gestures
Cinnucet
Kming gestures
Flexion movements of body
1 iH j / 11«
Screaming
Sniffing
TOTAL
C M 3
A/o/nr tics
Pounding stomach
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Touching head
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Screaming
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Neuropsychological effects
The general intelligence level in both tested patients (Cases 1 and 3) was average
to above average (intelligence quotient 10« and 114. respectively). I'reopera-
tively, these patients showed borderline to low results on verbal memory testing,
and the patient in Case 3 performed below average on facial recognition.
Postoperatively. the patient in Case 1 showed little or no change on the same tests
pertonTied preoperatively. In the patient in Case 3 the results on most timed usks
were lower, including visual reaction time and word fluency, which, seeming
Table 2 Seventy of des, obsessions and compulsions per patient and per tic
Tic characteristics Preop Postop
Case 1
7io
Licking of objects/shoulders +++ 0
Turning movement« of head +++ +
Throat clearing ++ 0
Uttering sounds ++ +
Blowing ++ +
Adduction of knees ++ +
Eye blinking 0 +
Checking (doors etc) ++ 0
Cas. 2
77«
Head shaking +++ 0
Screaming +++ 0
Obscene finger gestures +++ 0
Cinmaces
Kissing gestures
Sniffing ++ 0
Hitting head ++ +
Turning movements of head ++ 0
Flexion movement* of body + 0
Touching people
AutomutiLition with cigarettes
Case 3
7 V«
Screaming
Pounding stomach
Flexion movements of head
Grimaces/ Tongue pulling
Touching head + + + 0
Throat clearing ++ 0
Smiling ++ 0
Coughing ++ 0
Hreiking glass + + + 0
(I: symptoms absent; +: symptoms leading to minimal problems in self-esteem, familial or socioprofessional
life; +•+: symptoms leading to moderate problems in sell-esteem, familial or socioprofessional life; + + + : very
intense symptoms leading to very low selt-esteeni and social isolation.
Table
Pat
1
2
3
3 Stimulation characteristics at 2-months and at long-term follow-up in
Electrode Setting
2-mos FU
It rt
O-.1-/2+.3+ l)- , l - /2+,3+
7- / Case+ 2-.3- / Case+
4-.5-/ Case+ O-.l-/Case+
LTFU
It
O-.I-/2+.3+
7- / Case+
5- / Case+
rt
O-.l- / 2+,3+
2-.3- / Case+
1- / Case+
three patients with TS who received bilateral thalarruc stimulation.
Frequencency
2-mo$ FU
75
65
130
LTFU
100
65
100
Amplitude in Voki
2-mos FU
It
25
2.7
2.0
rt
25
2.7
24
LTFU
k
22
2.8
2.4
rt
2.4
3.0
2.8
PWin
2-moi
210
210
210
microtcc
LTFU
210
210
210
Each electrode has 4 poles with 0 most ventral and 3 most dorsal, or 4 most ventral and 7 mou dorul When case is +, the stimulation u monopolar. In all paaenti the freqtwncy and
the puKe width (I>W) are the same for the left and nght side at 2 months and at long-term follow-up 2 m»at 2 month foUow-up. FU=foDow-up, LT» long term. R«nghU.»left;
microsec=microseconds.
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vulnerable preoperatively, now fell below average in four of five categories. Ver-
bal memory and facial recognition scores increased, indicating a possible retest
effect.
Stimulation parameters
The stimulation parameters for each patient at 2 months and at the long-term fol-
low-up are shown in Table 3.
Side effects and complications
All patients described a feeling of reduced energy at the stimulus voltage necessary
for the best effect on their tics. One patient (Case 1) experienced it as being very
pleasant. At the long-term follow-up, however, he reported that he preferred to
lower the stimulation intensity during physical exercise, as did the other two
patients.
At the long-term follow- up, the patient in Case 1 reported an increased sexual
drive, and the patient in Case 3 complained of reduced sexual potency and ejacu-
J lation. These functions were examined by a sexologist during stimulation-on and-offconditions (except for ejaculation) and were found to be stimulation- related.
98 Two patients (Cases 1 and 3) each underwent three revisions of the pulse genera-
tor and extension cable because of traction pain.
D I S C U S S I O N
In all three patients there was clearly a positive effect on the number of tics per
10-minute period before and after chronic bilateral stimulation. The number of
tics did not necessarily reflect the impact of the tics on the patient's self-esteem and
socio-professional life. Furthermore, not all tics exhibited by the patient during
the last month prior to surgery were recorded on the videotape; for example, on
the preoperative video of the patient in Case 3, we did not see him pounding him-
self in the stomach. It is a well-investigated phenomenon that patients with TS
who are videotaped at home exhibit a wider variety of tics than those who are vid-
eotaped in the clinician's office''. Given that we did not videotape these patients
at homo, we relied not only on the videotapes recorded in the hospital, but also on
anamnestic and heteroanamnestic data. Moreover, the number as well as the
intensity of the tics might be different, for example, in the case of the grimaces.
For all these reasons, we preferred to present the impact of the tics on the patient's
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life, as shown in Table 2. In all patients, the remaining symptoms only had a
minimal impact on their lives.
After switching the stimulator off for 12 hours, symptoms did not return to base-
line (Table 1). We considered this to be an after-effect of stimulation. One might
criticize the effect of stimulation and infer that the reduction in symptoms was due
to the natural evolution of the disease. We consider it highly unlikely that these
patients with TS. which had been refractory to any kind of conservative treat-
ment, would have such a spontaneous reduction in symptoms without presenting
new ones. Only in the patient in Case I did eye- blinking become apparent after
switching the stimulator off.
All three patients suffered from compulsions preoperatively. Compulsions consist
of repetitive, seemingly purposeful types of behaviors that are performed to cer-
tain rules or in a stereotyped fashion.
Obsessive-compulsive and self-injurious behaviors completely disappeared in all
patients (Table 2), even when both stimulators were switched off.
In the past, many different lesioning procedures have been performed on patients
with TS. Frontal lobe operations have included prefrontal lobotomies^- "•-' and
bimedial frontal leucotomies*- 2?. The limbic system was targeted during limbic
leucotomy^-^ and cingulotomy''^"-^' with or without hypothalamotomy.
Thalamic operations have included lesions of the medial, iiitr.il.unin.ir and
ventrolateral thalamic nuclei-'- """•• "'"'"• -™. Infrathalainic lesions were created at
the level of Forel's field (campotomies), the zona incerta, and the red nucleus -• •'•''•
22. Cerebellar surgery has included dentatotomies^. The majority of the reports
lack any specification of the tic reduction or any rationale for choosing a specific
target. Hassler and Dieckmann"'"'**, however, presented a detailed report of the
successful results achieved by creating lesions in the midline and intralaminar
thalamic nuclei as a treatment for TS in nine patients. In patients with facial tics,
they additionally created lesions of the nucleus ventrooralis interims. Based on
these positive results and actual knowledge of the pathophysiological features of
T<j25,26^  ^,p decided to target the same thalamic nuclei in patients with intractable
TS. Rather than lesioning these nuclei, however, we applied high- frequency
stimulation. In the course of the neurosurgical treatment of Parkinson disease and
tremor, HFS has been shown to have effects on symptoms similar to those of
lesioning. HFS, however, is safer and has the advantage that its effects can be mod-
ulated in accordance with the patient's needs.
Various clinical, neuropathological and neuro-imaging observations indicate that
a dysfunctioning of the basal ganglia and related thalamocortical circuits form, at
least in part, the pathophysiological basis of T S ' - '•*• '*• ^ ^ - •**• **• **. It is assumed
that the basal ganglia play a major role in the " t iming and sequencing" of m o t o r
and behavioral programs by selecting desired and by suppressing unwanted p r o -
grams to be executed*" ^>. In this way, the basal ganglia "assist" the (pre) frontal
cortex in facilitating or by suppressing behavioral or mo to r responses'- *• Thus ,
the uncontrol led movements and vocalizations in TS might be the result of defec-
tive inhibitory mechanisms at the level of the basal ganglia, leading to the expres-
sion of simple or more complex fragments of otherwise purposeful mo to r or
behavioral act. T h e thalamic involvement in the aforementioned circuits is dual
in nature. Whereas the medial and ventral thalamic nuclei are way stations within
these circuits that lead back to the p remotor and prefrontal cortices from which
the circuits originate, the midline and intralaminar thalamic nuclei send projec-
tions to both the p remotor and prefrontal cortex and the striatuin. Therefore, the
basal gangha-thalamocortical circuits are strongly influenced at the level of their
major input (the striatum) by excitatory thalamic input. It has been hypothesized
that in this way the midline and intralaminar thalamic nuclei may strongly influ-
ence the level of activity in these circuits ' ' ' . T h e caudal intralaminar thalamic
nuclei, the presumptive target of our HFS electrodes in the present study, are
us thought to play a major role in l imbic-motor functions, whereas other, more
i rostral intralaminar nuclei are thought to be involved in cognitive and attentionalfunctions""'. In determining the level of activity of the striatum, the midline and
mtr.il.miiiur thalamic nuclei might play an important role in the gating of the ou t -
put of the basal ganglia to the thalamocortical system and the brain stem.
Lesioning or inhibiting these nuclei by H FS may, at least in part, close the gate.
According to the target coordinates used in our study, we believe that the three
groups of nuclei that were lesioned by Hassler and Dieckmann are affected by the
stimulation used in our study in the centromedian nucleus (as part of the
intr.il.imnur thalamic nuclei), the substantia periventricularis (as part of the
midline thalamic nuclei), and the nucleus ventrooralis internus (Fig 2).
Nonetheless, with the amplitudes used and the altered position of the right elec-
trode in the patient in Case 1 (by 2 nun) , and the left electrode in the patient in
Case 3 (also by 2 m m ) , we cannot exclude the possibility that o ther adjacent
nuclei were also influenced.
T h e reversibility of the effect of stimulation is very important for these patients
because of the sedative effect that accompanies the positive effects on the tics. T h e
patient p rogrammer enables them to control the stimulus intensity and hence the
level of energy that they prefer based on the situation in which they find t hem-
selves.
Thalamic samubnon in Tourrttc syndrome 101
f Brain item )
Figure 2. Schematic representation illmttuniij; ihr uiyri otMmuiljiixii /Xxrr<i /nif rrprorni (lie nuipiil.
hvpHXliciually rrducrd by chc itumiUuon tuwanl the iium cuit|>iu «mit'lum ol ihr urgrinl iniilci
C>=ccnm>nicdun nucleus: Spv=sub«unaa pcnvrntnculan«, Voi=nuilcu» vrnmioril» inirnmi. III—third
venmele
The effects on sexual behavior in the patients in Cases 1 and 3 might be explained
by stimulation of the caudal intralaminar thalamic nuclei-"'. Thus, data from pre-
dinical studies indicate that the posterior intralaminar thalamic nuclei are possibly
involved in processing the sexual outflow from the spinothalamic pathway
towards the preoptic area, the temporal lobe and the frontal cortex-"'.
CONCLUSIONS
Chronic thalamic stimulation could well be an effective and safe treatment for
intractable TS. Caution with regard to unwanted stimulation-induced side effects
is warranted.
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Conclusion
In the pre-DBS era, uiul.itfr.il pallidotomies were considered the treatment of
choice in advanced Parkinson disease to alleviate all motor symtoms In chapter 1
we describe the long-term motor effects of unilateral pallidal stimulation in 2(>
patients with a mean follow-up of 32.7 months (minimum of 24 months) The
effects are not good at long term, making unilateral pallidal stimulation an unat-
tractive treatment option for I'D patients. Since this long-term effect is not only
unsatisfactory' on the side ipsil.itcr.il to the stimulation and on axial symptoms, but
also on the contralateral symptoms, we consider the question: 'would bilateral
pallidal stimulation be a favourable option in PD?' to be redundant.
We conclude that the globus pallidus intemus is not a favourable target for I HIS in
advanced PD.
Our results described in chapter 2 confirm the beneficial effects of bilateral SIN
stimulation presented in other studies, all of which, however, have a limited fol-
low-up period. We investigated the effects in 20 patients, each with a minimum
follow-up of four years. We found that the positive effect on motor function,
ADL, and functional performance is maintained. This strengthens the value of
bilateral STN DBS for PD patients who suffer from the complications of chronic
levodopa treatment. Moreover, the implantation of electrodes appears to be a safe
technique, as shown in oui study and in the others reviewed in chapter 2. One
side effect of stimulation of the STN is, however, rather concerning, and that is
that the patient's mood, and even personality, can change due to the stimulation.
Of the 20 patients described in chapter 2, four presented with hypomanic to
manic features. One patient had to be excluded from this study because he com-
mitted suicide before four years of follow-up had been reached.
We conclude that behavioral changes following STN DBS are not rare We
believe that this fact will give an extra impetus to research into alternative treat-
ment options for patients with advanced PD, e.g. transplantation of
dopaminergic cells. At this moment in time, there is no alternative.
For patients who have undergone a pallidotomy and in whom motor symptoms
on the side ipsilateral to the lesion or axial problems like gait freezing develop, the
question could arise: would the patient be better off with contralateral unilateral
pallidal stimulation or with bilateral STN stimulation? A unilateral STN stimula-
tion after pallidotomy is not an option because of conflicting postoperative medi-
cation requirements. When the risks of behavioral changes are taken into
account, one would choose unilateral pallidal stimulation. The results described
in chapter 1 however lead to the conclusion that also in these patients bilateral
STN stimulation is the treatment of choice.
In chapter 3 we showed that performing STN DBS in patients with multiple sys-
tem atrophy-parkinsonism is justifiable. We performed a bilateral STN DBS in
four patients with MSA-1'. Although the effects were tar less pronounced than in
patients with PI), we showed that bilateral STN DBS was beneficial to these
patients, since, on the one hand, there were no alternatives, and on the other, the
patients' functional performance would clearly have been worse without stimu-
lation, as demonstrated by the results with the stimulators being switched off for
12 hours.
While, in our opinion, DBS will probably be replaced by transplantations in the
Ü'' treatment of advanced PD in the future, we believe this technique will remain
indispensable for diseases in which there is no chemical deficiency, as in Tourette
syndrome (TS). We find this an interesting study object as it lies at the other
extreme of the spectrum compared to I'D. In I'D, a dopamine deficiency
accounts for the motor symptoms. In TS, there is probably a dopaminergic
hypermetabolism. In the past, there have been numerous attempts to operate on
patients with intractable TS, all involving the destruction of various parts of the
brain. Frontal lobe operations included prefrontal lobotomies and bimedial fron-
tal leucotomies. The limbic system was targeted during limbic leucotomy and
anterior cingulotomy. Thalainic operations included lesioning of the medial,
intralaminar and ventrolateral thalamic nuclei. Infrathalamic lesions were per-
formed at the level of Forel's fields (campotomies) and the zona incerta. Cerebel-
lar surgery included dentatotomies. In an attempt to achieve total control of
symptoms, more complex operations have been performed such as combined
anterior cingulotomies and infrathalamic lesions. We review all of these in chap-
ter 4. The lack of rationale for choosing specific targets for these ablative proce-
dures is striking and makes most of them hazardous from an ethical point of view,
especially when the complications are taken into consideration. These vary from
dystonia to even quadriplegia.
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Since we know from the history of surgery for PD that HFS mimics the effects of a
lesion, but with far fewer complications, we performed the first PBS in a
Tourette patient in 1997. Relying on the beneficial ertects of thalamotomies in
TS described by Hassler in 1970, we performed a bilateral thalanuc stimulation in
this patient, with a good result. In chapter 5. we describe the long-term effects
(5yrs, lyr. and 8 mos. resp.) in three patients with intractable TS, who underwent
bilateral thalamic stimulation. The results on the tics are very good, with a tic
reduction of 90.1%. 72.2% and 82.6%. respectively. The positive effects on the
behavioral disorders, from which approximately (>0% ot TS patients sutler, are
also very promising. Side effects include a stimulation-induced lower state of
arousal in all three, and changes in sexual behavior in two.
After more than fifteen years of experience with DBS. we believe it is important
to stay critical and to keep re-evaluating the effects in the long ten«. Special atten-
tion should be paid to side effects which are not apparent at first glance. Team-
work involving not only neurosurgeons and neurologists, but also neuro-
psychologists and psychiatrists, is of great importance in the field of DBS. We
consider this to be even more important than the use of the most sotist it at cd
neurosurgical techniques, since the positive effects of STN stimulation in our
study were obtained by a relatively simple technical procedure, with target deter-
mination on CT-scan, without depth-recordings.
From our point of view, the safety offered by 1 )BS makes the technique of creat-
ing permanent lesions in new indications unethical. Unwanted side effects can
occur, and may even appear when the patient is at home (cf. the changes in sexual
behavior in the two TS patients) but these can be reversed in the case ofDBS.
A final remark is that we believe the advantages and possibilities of 1 )BS should be
further exploited. Even in patients with a relatively short life-expectancy with
symptoms which react less to DBS than in PI), I )BS might be of great value result-
ing in their functional performance being considerably better than without stim-
ulation.
108
10*
Conclusie
In hct prc-DBS tijdperk wcrd de unilaterale pallidotomie beschouwd als de voor-
keursbchandeling voor Parkinsonpatienten die conservatief waren uitbeliandold,
met een gunstig effect op de verschillende motore verschijmelen.ln hooUKtuk I
werden de lang-tennijn motorische effecten beschreven van de unilaterale palli-
dale stimulatie bij 26 patienten met een gemiddelde follow-up van 32,7 maanden
(met een minimum van 24 maanden). Deze resultaten 7ijn onbovredigoiul. met
alleen voor wat betreft de ipsilaterale en axiale Symptomen, inaar ook voor ile
contralaterale. Deze bevindingen maken ons inziens de vraag of de bilaterale pal-
lidale stimulatie een goede therapeutische keuzc zou kunnen zijn, overbodig.
Wij concluderen dat de globus pallidus intenius geen gunstige target is voor I )HS
bij de ziekte van Parkinson.
l)e resultaten beschreven in hoofdstuk 2 bcvcstigen de positieve effecten van
bilaterale stimulatie van de nucleus subthalamicus (STN) die in andere studies
beschreven zijn. Deze hebben evenwel alle een beperkte follow-up. Wij hebben
de lange termijn effecten bestudeerd bij 20 patientcn, elk met een minimum fol-
low-up van 4jaar. We vonden dat het positieve effect op de motorische hiiR ties,
het uitvoeren van de dagelijkse activiteiten en het algemeen functioneren, op
deze lange termijn behouden blijft. Hit versterkt de waarde van de bilaterale STN
stimulatie bij patienten die lijden onder de complicates van het chronisch levo-
dopagebniik. Bovendien blijkt de implantatie van electroden in de STN een
veilige techniek te zijn, zoals blijkt uit onze studie en andere studies die in hoofd-
stuk 2 vernoemd worden. Een neveneffect van de bilaterale STN stimulatie
evenwel is onrustwekkend, en dat is dat er postoperatieve stimulatiegebonden
stemmings-, en gedragsafwijkingen kunnen optreden. Van de 20 patienten
beschreven in hoofdstuk 2 vertoonden er vier hypomane tot manische kenmer-
ken. Een patient was geexcludeerd van deze studie omwille van suicide voör de
tennijn van vier jaar follow-up was bereikt.
Wij concluderen dat gedragsveranderingen na bilaterale STN DBS niet zelden
voorkomen. Dit zal ons inziens een extra motivatie zijn voor verder onderzoek
voor alternatieve behandelingsmethoden voor Parkinsonpatienten die conserva-
tief zijn uitbehandeld, bijvoorbeeld transplantaties van dopaminerge cellen.
Voor patienten die in het verleden een pallidotomie hebben ondergaan en die
Symptomen ontwikkelen ipsilateraal aan de lesie, of gangmoeilijkheden, kan de
vraag rijzen of het beter is een contralaterale unilaterale pallidale stiinulatie uit te
voeren, dan wel een bilaterale STN stiinulatie. Een unilaterale STN stimulatie is
gecn optie omwille van het tegengestelde medicatiebeleid postoperatief na een
pallidotomie en een subthalamische stimulatie. Wanneer men de kans op
gedragsveranderingen in overweging neemt, zou men voor de contralaterale pal-
lidale stimulatie kiezen. Bovendien is de kans op een bloeding theoretisch kleiner
bij een unilaterale, dan bij een bilaterale stimulatie. Toch leiden de resultaten van
onze Studie tot de conclusie dat ook in deze patientengroep een bilaterale STN
stimulatie de beste keuze is.
In hoofdstuk 3 hebben wij aangetoond dat STN stimulatie een verdedigbare the-
rapeutische optie is voor patienten met MSA-P ("multiple system atrophy-par-
kinsonism") I )eze operatic word bij vier MSA-P patienten uitgevoerd. Alhoewel
de eticcten minder goed waren dan die van STN stimulatie bij de ziekte van Par-
kinson, hebben wij aangetoond dat deze patienten baat hadden bij deze operatie,
omdat zij beduidend minder goed hinctioneerden nadat de stroom uitgezet was
godurendc 12 uur, hetgeen resprcsentatief is voor him toestand die zij op dat
moment zuuden vcrtoond hebben zonder operatie.
Terwij! DBS n.ur onze mening in de toekomst waarschijnlijk vervangen zal wor-
den door transplantaties van dopaminerge cellen, geloven wij dat deze techniek
onvervangbaar zal blijven in de behandeling van aandoeningen waarbij er geen
tekort aan neurotransinitters kan worden aangetoond, zoals bij het Tourette syn-
droom (TS). TS is een interessant studieobjeet voor DBS omdat het op het andere
uiteinde van het spectrum ligt vergeleken met de ziekte van Parkinson. Bij de
ziekte van Parkinson ligt een tekort aan dopamine aan de basis van de klinische
verschijnselen. In TS is er waarschijnlijk een dopaminehypennetabolisme. In het
verleden zijn er multipcle soorten operaties uitgevoerd bij patienten met thera-
pieresistent TS. Ingrepen ter hoogte van de frontaalkwab omvatten pretrontale
lobotomieen en bimediale frontale leueotomeen. Er werden lesies uitgevoerd ter
hoogte van het limbisch systeein tijdens de limbische leueotomieen en anterieure
cingulotomicen. Ingrepen ter hoogte van de thalamus bestünden ondenneer uit
het aanbrengen van lesies ter hoogte van de mediaal gelegen, intralaminaire en
ventrolaterale kenien. Infrathalamische lesies werden uitgevoerd op het niveau
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van het veld H van Forel (campotomieen) en de zona incerta. Ook cerebellaire
ingrepen. met name dentatotomieen. werden uitgevoerd bij Tourettepaticnten.
In een poging om alle Symptomen te behandelen werden ook complexe operatic«
uitgevoerd zoals een combmarie van anteneure cmgulotomieen en mfrathalami-
sche lesies. Hoofdstuk 4 omvat een samenvattmg van al deze ingrcpcn. Met
gebrek aan rationale voor het kiezen van een bepaalde target om een irreversible
lesie te maken is frappant. Dit maakt deze ingrepen moeilijk ethisch te verdedi-
gen. vooral wanneer men de complicacies voor ogen houdt. I )eze vaneerden van
dystonie tot quadnplegie.
Omdat HFS hetzelfde klinisch effect heeft als een lesie, niaar dan op een reversi-
bele manier, hebben wij in 1997 voor het eerst DBS uitgevoerd bij een patient
met retractair Tourette syndroom.Cicbaseerd op de günstige effecten van thala-
motomieen die Hassler in 1970 beschreven heeit. hebben wij bij deze patient een
bilaterale stimulatie uitgevoerd van het mediale gedeelte van de thalanuis, met
een gunstig resultaat. In hoofdstuk 5 presenteren wij de resultaten van een bilate-
rale thalamische stimulatie bij 3 patienten met TS, na een follow-up van resp. 5
jaar, 1 jaar en 8 maanden. l)e effecten op dc tics zijn positicf. met een ticreductie
van resp. 90,1%, 72,2% en 82,6%. Ook op dc gcdragsat'wijkingen, waaraan W)%
van dc Tourettepatienten lijdt, was er een gunstig effect. Als nevenwerkingen
venneldden de drie patienten het gevoel van minder energie te hebben bij die
voltage die noodzakelijk was voor een optimaal effect op de tics. Uovendien
waren er stimulatiegebonden veranderingen in het sexueel gedrag bij twee
patienten.
Na meer dan 15 jaar ervaring met 1 )BS moeten we kritisch blijven cn de patienten
blijven herevalucren, ook op lange tcnnijn. We moeten steeds bedacht blijven op
stimulatiegebonden neveneffecten die op het eerste zieht met evident /ijn.
Teamwork, waarbij nict alleen neurologen en neurochirurgen betrokken zijn,
maar ook neuropsychologen en psychiaters, is zeer belangnjk voor I )BS! 1 )it vin-
den wij zelfs belangrijker dan het gebruik van de nicest gcsofisticcerde operatie-
technieken, gezien de positieve effecten van de STN stimulatie in deze studie via
een relatief een voudige procedure bekomen werden, namelijk met targctbepa-
ling op CT-scan, zonder diepteregistraties. Volgens ons maakt de veiligheid van
DBS vandaag de dag het maken van pennante lesies bij zogenaamde
"nieuwe"indicaties, zoals het Tourette syndroom, nog moeilijk ethisch te ver-
dedigen. Onverwachte neveneffecten kunnen optreden, zelfs relatief laat na de
ingreep, wanneerde patient ontslagen is uit het ziekenhuis (cfr de sexuele vcran-
denngen bij de twee Tourettepatienten). maar deze zijn reversibel in het geval
van DBS.
Wij geloven dat de voordelen en de mogelijkheden van DBS meer zouden moe-
ten worden benut. Zelfs bij patienten met een relatief beperkte levensverwach-
ting (zoals MSA-P patienten), waarbij de effecten van DBS minder spectaculair
zijn dan in het geval van de ziekte van Parkinson, kan DBS van grote waarde zijn
voor de patient omdat hun dagelijks functioneren beter is met stimulatie, verge-
leken met de toestand waarin ze zieh op dat moment zouden bevinden indien ze
nict zouden geopereerd zijn.
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